{
  "$schema": "folio-library-document/v1",
  "id": "9789241549912-websupplement-eng",
  "title": "WHO recommendations on antenatal care for a positive pregnancy experience (English)",
  "variant": "pdf",
  "pages": 129,
  "tocSource": "inferred",
  "tocMethod": "contents",
  "toc": [
    {
      "level": 2,
      "title": "Acronyms and abbreviations",
      "number": null,
      "page": null,
      "pageLabel": null,
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "number": null,
      "page": null,
      "pageLabel": null,
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "number": null,
      "page": null,
      "pageLabel": null,
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "number": null,
      "page": null,
      "pageLabel": null,
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "number": null,
      "page": null,
      "pageLabel": null,
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "number": null,
      "page": null,
      "pageLabel": null,
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "number": null,
      "page": null,
      "pageLabel": null,
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 2,
      "title": "Nutritional interventions",
      "number": "A",
      "page": 9,
      "pageLabel": "1",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-000-a-nutritional-interventions"
    },
    {
      "level": 2,
      "title": "Dietary interventions",
      "number": "A.1",
      "page": 9,
      "pageLabel": "1",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-001-a1-dietary-interventions"
    },
    {
      "level": 3,
      "title": "EB Table A.1.1: All diet and/or physical activity/exercise interventions versus control (standard or other care)",
      "number": null,
      "page": 9,
      "pageLabel": "1",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-002-eb-table-a11-all-diet-andor-physical-activityexe"
    },
    {
      "level": 3,
      "title": "Figure A.1.1: Additional meta-analysis: Effect of diet and/or exercise interventions versus control on gestational diabetes mellitus (GDM)",
      "number": null,
      "page": 16,
      "pageLabel": "8",
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": "sec-003-figure-a11-additional-meta-analysis-effect-of-di"
    },
    {
      "level": 3,
      "title": "EB Table A.1.2: Energy and protein nutrition education during pregnancy versus control (no nutritional education or normal care)",
      "number": null,
      "page": 17,
      "pageLabel": "9",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 3,
      "title": "EB Table A.1.3: Energy and protein dietary supplements versus control",
      "number": null,
      "page": 18,
      "pageLabel": "10",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-004-eb-table-a13-energy-and-protein-dietary-suppleme"
    },
    {
      "level": 3,
      "title": "EB Table A.1.4: High-protein supplements versus control",
      "number": null,
      "page": 19,
      "pageLabel": "11",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-005-eb-table-a14-high-protein-supplements-versus-con"
    },
    {
      "level": 2,
      "title": "Iron and folic acid supplements",
      "number": "A.2",
      "page": 20,
      "pageLabel": "12",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-006-a2-iron-and-folic-acid-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.2.1: Daily iron and folic acid supplements versus control (supplements without iron or no treatment/placebo)",
      "number": null,
      "page": 20,
      "pageLabel": "12",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-007-eb-table-a21-daily-iron-and-folic-acid-supplemen"
    },
    {
      "level": 3,
      "title": "EB Table A.2.2: Intermittent iron and folic acid supplements versus daily regimen with no iron",
      "number": null,
      "page": 24,
      "pageLabel": "16",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-008-eb-table-a22-intermittent-iron-and-folic-acid-su"
    },
    {
      "level": 2,
      "title": "Calcium supplements",
      "number": "A.3",
      "page": 27,
      "pageLabel": "19",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-009-a3-calcium-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.3: Calcium supplements versus placebo or no treatment",
      "number": null,
      "page": 27,
      "pageLabel": "19",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-010-eb-table-a3-calcium-supplements-versus-placebo-o"
    },
    {
      "level": 2,
      "title": "Vitamin A supplements",
      "number": "A.4",
      "page": 30,
      "pageLabel": "22",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-011-a4-vitamin-a-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.4: Vitamin A supplements alone versus placebo or no treatment",
      "number": null,
      "page": 30,
      "pageLabel": "22",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-012-eb-table-a4-vitamin-a-supplements-alone-versus-p"
    },
    {
      "level": 2,
      "title": "Zinc supplements",
      "number": "A.5",
      "page": 32,
      "pageLabel": "24",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-013-a5-zinc-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.5: Zinc supplements versus no intervention or placebo",
      "number": null,
      "page": 32,
      "pageLabel": "24",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-014-eb-table-a5-zinc-supplements-versus-no-intervent"
    },
    {
      "level": 2,
      "title": "Multiple micronutrient (MMN) supplements",
      "number": "A.6",
      "page": 34,
      "pageLabel": "26",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-015-a6-multiple-micronutrient-mmn-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.6: Multiple micronutrient supplements versus iron (with or without folic acid)1",
      "number": null,
      "page": 34,
      "pageLabel": "26",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-016-eb-table-a6-multiple-micronutrient-supplements-v"
    },
    {
      "level": 3,
      "title": "Additional meta-analyses on the effect of MMN supplements",
      "number": null,
      "page": 36,
      "pageLabel": "28",
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 3,
      "title": "i. Subgroup analyses grouping trials according to dose of iron in the control group",
      "number": null,
      "page": 36,
      "pageLabel": "28",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-017-i-subgroup-analyses-grouping-trials-according-to"
    },
    {
      "level": 1,
      "title": "Meta-analyses of trials evaluating UNIMMAP supplements with trials grouped according to dose of iron in the control group",
      "number": "ii",
      "page": 47,
      "pageLabel": "39",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-018-ii-meta-analyses-of-trials-evaluating-unimmap-su"
    },
    {
      "level": 2,
      "title": "Vitamin B6 (pyridoxine) supplements",
      "number": "A.7",
      "page": 56,
      "pageLabel": "48",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-019-a7-vitamin-b6-pyridoxine-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.7: Vitamin B6 (pyridoxine) supplements versus control",
      "number": null,
      "page": 56,
      "pageLabel": "48",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-020-eb-table-a7-vitamin-b6-pyridoxine-supplements-ve"
    },
    {
      "level": 2,
      "title": "Vitamin E and C supplements",
      "number": "A.8",
      "page": 57,
      "pageLabel": "49",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-021-a8-vitamin-e-and-c-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.8a: Vitamin E and C supplementation versus placebo or no treatment",
      "number": null,
      "page": 57,
      "pageLabel": "49",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-022-eb-table-a8a-vitamin-e-and-c-supplementation-ver"
    },
    {
      "level": 3,
      "title": "EB Table A.8b: Vitamin C supplementation alone versus placebo or no treatment",
      "number": null,
      "page": 60,
      "pageLabel": "52",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-023-eb-table-a8b-vitamin-c-supplementation-alone-ver"
    },
    {
      "level": 2,
      "title": "Vitamin D supplements",
      "number": "A.9",
      "page": 61,
      "pageLabel": "53",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-024-a9-vitamin-d-supplements"
    },
    {
      "level": 3,
      "title": "EB Table A.9: Vitamin D supplementation alone or with calcium versus placebo or no treatment",
      "number": null,
      "page": 61,
      "pageLabel": "53",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-025-eb-table-a9-vitamin-d-supplementation-alone-or-w"
    },
    {
      "level": 2,
      "title": "Restricting caffeine intake",
      "number": "A.10",
      "page": 63,
      "pageLabel": "55",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-026-a10-restricting-caffeine-intake"
    },
    {
      "level": 3,
      "title": "EB Table A.10a: Caffeinated coffee versus decaffeinated coffee",
      "number": null,
      "page": 63,
      "pageLabel": "55",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-027-eb-table-a10a-caffeinated-coffee-versus-decaffei"
    },
    {
      "level": 3,
      "title": "EB Table A.10b: Non-randomized evidence of effect of caffeine on low birth weight – 1",
      "number": null,
      "page": 64,
      "pageLabel": "56",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-028-eb-table-a10b-non-randomized-evidence-of-effect"
    },
    {
      "level": 3,
      "title": "EB Table A.10b: Non-randomized evidence of effect of caffeine on low birth weight – 2",
      "number": null,
      "page": 64,
      "pageLabel": "56",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 3,
      "title": "EB Table A.10c: Non-randomized evidence of effect of caffeine on pregnancy loss – 1",
      "number": null,
      "page": 65,
      "pageLabel": "57",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-029-eb-table-a10c-non-randomized-evidence-of-effect"
    },
    {
      "level": 3,
      "title": "EB Table A.10c: Non-randomized evidence of effect of caffeine on pregnancy loss – 2",
      "number": null,
      "page": 66,
      "pageLabel": "58",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 2,
      "title": "Maternal and fetal assessment",
      "number": "B",
      "page": 67,
      "pageLabel": "59",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-030-b-maternal-and-fetal-assessment"
    },
    {
      "level": 2,
      "title": "Maternal assessment",
      "number": "B.1",
      "page": 67,
      "pageLabel": "59",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-031-b1-maternal-assessment"
    },
    {
      "level": 3,
      "title": "EB Table B.1.1a: Anaemia (test accuracy): haemoglobinometer method for diagnosing anaemia (Hb < 11 g/dL) in pregnancy",
      "number": null,
      "page": 67,
      "pageLabel": "59",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-032-eb-table-b11a-anaemia-test-accuracy-haemoglobino"
    },
    {
      "level": 3,
      "title": "EB Table B.1.1b: Anaemia (test accuracy): Hb Colour Scale method for diagnosing anaemia (Hb < 11 g/dL) in pregnancy",
      "number": null,
      "page": 67,
      "pageLabel": "59",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-033-eb-table-b11b-anaemia-test-accuracy-hb-colour-sc"
    },
    {
      "level": 3,
      "title": "EB Table B.1.2a: Asymptomatic bacteriuria (ASB): dipstick (nitrites or leukocytes) for diagnosing ASB in pregnancy",
      "number": null,
      "page": 68,
      "pageLabel": "60",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-034-eb-table-b12a-asymptomatic-bacteriuria-asb-dipst"
    },
    {
      "level": 3,
      "title": "EB Table B.1.2b: Asymptomatic bacteriuria (ASB): Gram staining for diagnosing ASB in pregnancy",
      "number": null,
      "page": 68,
      "pageLabel": "60",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-035-eb-table-b12b-asymptomatic-bacteriuria-asb-gram"
    },
    {
      "level": 3,
      "title": "EB Table B.1.3: Intimate partner violence (IPV): screening women for IPV",
      "number": null,
      "page": 69,
      "pageLabel": "61",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-036-eb-table-b13-intimate-partner-violence-ipv-scree"
    },
    {
      "level": 2,
      "title": "Fetal assessment",
      "number": "B.2",
      "page": 70,
      "pageLabel": "62",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-037-b2-fetal-assessment"
    },
    {
      "level": 3,
      "title": "EB Table B.2.1: Routine daily fetal movement counting versus usual practice (mixed or undefined fetal movement counting)",
      "number": null,
      "page": 70,
      "pageLabel": "62",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 3,
      "title": "EB Table B.2.2: Symphysis-fundal height (SFH) measurement versus clinical palpation",
      "number": null,
      "page": 71,
      "pageLabel": "63",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-038-eb-table-b22-symphysis-fundal-height-sfh-measure"
    },
    {
      "level": 3,
      "title": "EB Table B.2.3: Routine antenatal cardiotocography (CTG) versus no routine antenatal CTG",
      "number": null,
      "page": 71,
      "pageLabel": "63",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-039-eb-table-b23-routine-antenatal-cardiotocography"
    },
    {
      "level": 3,
      "title": "EB Table B.2.4a: Early ultrasound scan (< 24 weeks of gestation) versus selective/concealed ultrasound scan in early pregnancy)",
      "number": null,
      "page": 72,
      "pageLabel": "64",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-040-eb-table-b24a-early-ultrasound-scan-24-weeks-of"
    },
    {
      "level": 3,
      "title": "EB Table B.2.4b: Late ultrasound scan (> 24 weeks of gestation) versus no, concealed or selective late ultrasound scan",
      "number": null,
      "page": 73,
      "pageLabel": "65",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-041-eb-table-b24b-late-ultrasound-scan-24-weeks-of-g"
    },
    {
      "level": 3,
      "title": "EB Table B.2.5a: All routine Doppler ultrasound (of fetal blood vessels) versus no Doppler ultrasound in normal pregnancy",
      "number": null,
      "page": 74,
      "pageLabel": "66",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 3,
      "title": "EB Table B.2.5b: Multiple Doppler ultrasound versus no Doppler ultrasound in normal pregnancy",
      "number": null,
      "page": 75,
      "pageLabel": "67",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-042-eb-table-b25b-multiple-doppler-ultrasound-versus"
    },
    {
      "level": 3,
      "title": "EB Table B.2.5c: Single Doppler ultrasound versus no Doppler ultrasound in normal pregnancy",
      "number": null,
      "page": 76,
      "pageLabel": "68",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-043-eb-table-b25c-single-doppler-ultrasound-versus-n"
    },
    {
      "level": 2,
      "title": "Preventive measures",
      "number": "C",
      "page": 77,
      "pageLabel": "69",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-044-c-preventive-measures"
    },
    {
      "level": 2,
      "title": "Antibiotics for asymptomatic bacteriuria (ASB)",
      "number": "C.1",
      "page": 77,
      "pageLabel": "69",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-045-c1-antibiotics-for-asymptomatic-bacteriuria-asb"
    },
    {
      "level": 3,
      "title": "EB Table C.1: Antibiotics for ASB versus no treatment",
      "number": null,
      "page": 77,
      "pageLabel": "69",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-046-eb-table-c1-antibiotics-for-asb-versus-no-treatm"
    },
    {
      "level": 2,
      "title": "Antibiotic prophylaxis to prevent recurrent urinary tract infections (RUTI)",
      "number": "C.2",
      "page": 79,
      "pageLabel": "71",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-047-c2-antibiotic-prophylaxis-to-prevent-recurrent-u"
    },
    {
      "level": 3,
      "title": "EB Table C.2: Antibiotic prophylaxis to prevent recurrent urinary tract infections (RUTI) versus control",
      "number": null,
      "page": 79,
      "pageLabel": "71",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-048-eb-table-c2-antibiotic-prophylaxis-to-prevent-re"
    },
    {
      "level": 2,
      "title": "Antenatal anti-D immunoglobulin prophylaxis",
      "number": "C.3",
      "page": 80,
      "pageLabel": "72",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-049-c3-antenatal-anti-d-immunoglobulin-prophylaxis"
    },
    {
      "level": 3,
      "title": "EB Table C.3: Antenatal anti-D immunoglobulin prophylaxis versus control",
      "number": null,
      "page": 80,
      "pageLabel": "72",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-050-eb-table-c3-antenatal-anti-d-immunoglobulin-prop"
    },
    {
      "level": 2,
      "title": "Preventive anthelminthic treatment",
      "number": "C.4",
      "page": 82,
      "pageLabel": "74",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-051-c4-preventive-anthelminthic-treatment"
    },
    {
      "level": 3,
      "title": "EB Table C.4: Preventive anthelminthic treatment versus control",
      "number": null,
      "page": 82,
      "pageLabel": "74",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-052-eb-table-c4-preventive-anthelminthic-treatment-v"
    },
    {
      "level": 2,
      "title": "Tetanus toxoid vaccination",
      "number": "C.5",
      "page": 83,
      "pageLabel": "75",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-053-c5-tetanus-toxoid-vaccination"
    },
    {
      "level": 3,
      "title": "EB Table C.5: Tetanus toxoid (TT) vaccination versus influenza vaccination",
      "number": null,
      "page": 83,
      "pageLabel": "75",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-054-eb-table-c5-tetanus-toxoid-tt-vaccination-versus"
    },
    {
      "level": 2,
      "title": "Interventions for common physiological symptoms",
      "number": "D",
      "page": 84,
      "pageLabel": "76",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-055-d-interventions-for-common-physiological-symptom"
    },
    {
      "level": 2,
      "title": "Nausea and vomiting",
      "number": "D.1",
      "page": 84,
      "pageLabel": "76",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-056-d1-nausea-and-vomiting"
    },
    {
      "level": 3,
      "title": "EB Table D.1a: P6 acupressure versus placebo",
      "number": null,
      "page": 84,
      "pageLabel": "76",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-057-eb-table-d1a-p6-acupressure-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1b: Auricular acupressure versus placebo",
      "number": null,
      "page": 85,
      "pageLabel": "77",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-058-eb-table-d1b-auricular-acupressure-versus-placeb"
    },
    {
      "level": 3,
      "title": "EB Table D.1c: Acustimulation therapy at P6 point versus placebo",
      "number": null,
      "page": 86,
      "pageLabel": "78",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-059-eb-table-d1c-acustimulation-therapy-at-p6-point"
    },
    {
      "level": 3,
      "title": "EB Table D.1d: Traditional acupuncture versus placebo",
      "number": null,
      "page": 86,
      "pageLabel": "78",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-060-eb-table-d1d-traditional-acupuncture-versus-plac"
    },
    {
      "level": 3,
      "title": "EB Table D.1e: P6 acupuncture versus placebo",
      "number": null,
      "page": 87,
      "pageLabel": "79",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-061-eb-table-d1e-p6-acupuncture-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1f: Ginger versus placebo",
      "number": null,
      "page": 88,
      "pageLabel": "80",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-062-eb-table-d1f-ginger-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1g: Lemon oil versus placebo",
      "number": null,
      "page": 89,
      "pageLabel": "81",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-063-eb-table-d1g-lemon-oil-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1h: Mint oil versus placebo",
      "number": null,
      "page": 89,
      "pageLabel": "81",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-064-eb-table-d1h-mint-oil-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1i: Chamomile versus placebo",
      "number": null,
      "page": 90,
      "pageLabel": "82",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-065-eb-table-d1i-chamomile-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1j: Vitamin B6 versus placebo",
      "number": null,
      "page": 90,
      "pageLabel": "82",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-066-eb-table-d1j-vitamin-b6-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1k: P6 acupressure versus vitamin B6",
      "number": null,
      "page": 91,
      "pageLabel": "83",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-067-eb-table-d1k-p6-acupressure-versus-vitamin-b6"
    },
    {
      "level": 3,
      "title": "EB Table D.1l: Traditional acupuncture versus P6 acupuncture",
      "number": null,
      "page": 91,
      "pageLabel": "83",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-068-eb-table-d1l-traditional-acupuncture-versus-p6-a"
    },
    {
      "level": 3,
      "title": "EB Table D.1m: Ginger versus P6 acupressure",
      "number": null,
      "page": 92,
      "pageLabel": "84",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-069-eb-table-d1m-ginger-versus-p6-acupressure"
    },
    {
      "level": 3,
      "title": "EB Table D.1n: Ginger versus chamomile",
      "number": null,
      "page": 92,
      "pageLabel": "84",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-070-eb-table-d1n-ginger-versus-chamomile"
    },
    {
      "level": 3,
      "title": "EB Table D.1o: Ginger versus vitamin B6",
      "number": null,
      "page": 93,
      "pageLabel": "85",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-071-eb-table-d1o-ginger-versus-vitamin-b6"
    },
    {
      "level": 3,
      "title": "EB Table D.1p: Vitamin B6 (high dose) versus vitamin B6 (low dose)",
      "number": null,
      "page": 94,
      "pageLabel": "86",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-072-eb-table-d1p-vitamin-b6-high-dose-versus-vitamin"
    },
    {
      "level": 3,
      "title": "EB Table D.1q: Ginger versus metoclopramide",
      "number": null,
      "page": 94,
      "pageLabel": "86",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-073-eb-table-d1q-ginger-versus-metoclopramide"
    },
    {
      "level": 3,
      "title": "EB Table D.1r: Doxylamine and pyridoxine versus placebo",
      "number": null,
      "page": 95,
      "pageLabel": "87",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-074-eb-table-d1r-doxylamine-and-pyridoxine-versus-pl"
    },
    {
      "level": 3,
      "title": "EB Table D.1s: Metoclopramide versus placebo",
      "number": null,
      "page": 95,
      "pageLabel": "87",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-075-eb-table-d1s-metoclopramide-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.1t: Ondansetron versus metoclopramide",
      "number": null,
      "page": 96,
      "pageLabel": "88",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-076-eb-table-d1t-ondansetron-versus-metoclopramide"
    },
    {
      "level": 3,
      "title": "EB Table D.1u: Ondansetron versus pyridoxine-doxylamine",
      "number": null,
      "page": 96,
      "pageLabel": "88",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-077-eb-table-d1u-ondansetron-versus-pyridoxine-doxyl"
    },
    {
      "level": 2,
      "title": "Interventions for heartburn",
      "number": "D.2",
      "page": 97,
      "pageLabel": "89",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-078-d2-interventions-for-heartburn"
    },
    {
      "level": 3,
      "title": "EB Table D.2a: Any pharmacological treatment versus placebo or no treatment",
      "number": null,
      "page": 97,
      "pageLabel": "89",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-079-eb-table-d2a-any-pharmacological-treatment-versu"
    },
    {
      "level": 3,
      "title": "EB Table D.2b: Pharmacological treatment versus lifestyle change",
      "number": null,
      "page": 98,
      "pageLabel": "90",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-080-eb-table-d2b-pharmacological-treatment-versus-li"
    },
    {
      "level": 3,
      "title": "EB Table D.2c: Acupuncture versus no treatment",
      "number": null,
      "page": 98,
      "pageLabel": "90",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-081-eb-table-d2c-acupuncture-versus-no-treatment"
    },
    {
      "level": 2,
      "title": "Interventions for leg cramps",
      "number": "D.3",
      "page": 99,
      "pageLabel": "91",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-082-d3-interventions-for-leg-cramps"
    },
    {
      "level": 3,
      "title": "EB Table D.3a: Oral magnesium versus placebo or no treatment",
      "number": null,
      "page": 99,
      "pageLabel": "91",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-083-eb-table-d3a-oral-magnesium-versus-placebo-or-no"
    },
    {
      "level": 3,
      "title": "EB Table D.3b: Oral calcium versus no treatment",
      "number": null,
      "page": 101,
      "pageLabel": "93",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-084-eb-table-d3b-oral-calcium-versus-no-treatment"
    },
    {
      "level": 3,
      "title": "EB Table D.3c: Vitamin B1 and B6 versus no treatment",
      "number": null,
      "page": 102,
      "pageLabel": "94",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-085-eb-table-d3c-vitamin-b1-and-b6-versus-no-treatme"
    },
    {
      "level": 3,
      "title": "EB Table D.3d: Oral calcium versus oral vitamin C",
      "number": null,
      "page": 102,
      "pageLabel": "94",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-086-eb-table-d3d-oral-calcium-versus-oral-vitamin-c"
    },
    {
      "level": 2,
      "title": "Interventions for low back and pelvic pain",
      "number": "D.4",
      "page": 103,
      "pageLabel": "95",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-087-d4-interventions-for-low-back-and-pelvic-pain"
    },
    {
      "level": 3,
      "title": "EB Table D.4a: Any exercise plus usual antenatal care (ANC) versus usual ANC",
      "number": null,
      "page": 103,
      "pageLabel": "95",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-088-eb-table-d4a-any-exercise-plus-usual-antenatal-c"
    },
    {
      "level": 3,
      "title": "EB Table D.4b: Bellybra versus Tubigrip support belts",
      "number": null,
      "page": 104,
      "pageLabel": "96",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-089-eb-table-d4b-bellybra-versus-tubigrip-support-be"
    },
    {
      "level": 3,
      "title": "EB Table D.4c: Acupuncture plus usual ANC versus usual ANC",
      "number": null,
      "page": 104,
      "pageLabel": "96",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-090-eb-table-d4c-acupuncture-plus-usual-anc-versus-u"
    },
    {
      "level": 3,
      "title": "EB Table D.4d: Acupuncture plus usual ANC versus individualized physiotherapy plus usual ANC",
      "number": null,
      "page": 105,
      "pageLabel": "97",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-091-eb-table-d4d-acupuncture-plus-usual-anc-versus-i"
    },
    {
      "level": 3,
      "title": "EB Table D.4e: Multimodal intervention (manual therapy/chiropractic, exercise at home and education) versus usual care (rest, exercise, heat pads and analgesics)",
      "number": null,
      "page": 105,
      "pageLabel": "97",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-092-eb-table-d4e-multimodal-intervention-manual-ther"
    },
    {
      "level": 2,
      "title": "Interventions for constipation",
      "number": "D.5",
      "page": 106,
      "pageLabel": "98",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-093-d5-interventions-for-constipation"
    },
    {
      "level": 3,
      "title": "EB Table D.5a: Fibre supplementation versus no intervention",
      "number": null,
      "page": 106,
      "pageLabel": "98",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-094-eb-table-d5a-fibre-supplementation-versus-no-int"
    },
    {
      "level": 3,
      "title": "EB Table D.5b: Stimulant laxatives versus bulk-forming laxatives",
      "number": null,
      "page": 107,
      "pageLabel": "99",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-095-eb-table-d5b-stimulant-laxatives-versus-bulk-for"
    },
    {
      "level": 2,
      "title": "Interventions for varicose veins and oedema",
      "number": "D.6",
      "page": 108,
      "pageLabel": "100",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-096-d6-interventions-for-varicose-veins-and-oedema"
    },
    {
      "level": 3,
      "title": "EB Table D.6a: Rutoside versus placebo",
      "number": null,
      "page": 108,
      "pageLabel": "100",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-097-eb-table-d6a-rutoside-versus-placebo"
    },
    {
      "level": 3,
      "title": "EB Table D.6b: External pneumatic intermittent compression versus rest",
      "number": null,
      "page": 109,
      "pageLabel": "101",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-098-eb-table-d6b-external-pneumatic-intermittent-com"
    },
    {
      "level": 3,
      "title": "EB Table D.6c: Reflexology versus rest",
      "number": null,
      "page": 109,
      "pageLabel": "101",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-099-eb-table-d6c-reflexology-versus-rest"
    },
    {
      "level": 3,
      "title": "EB Table D.6d: Water immersion versus leg elevation",
      "number": null,
      "page": 110,
      "pageLabel": "102",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-100-eb-table-d6d-water-immersion-versus-leg-elevatio"
    },
    {
      "level": 3,
      "title": "EB Table D.6e: Foot massage versus “routine care”",
      "number": null,
      "page": 110,
      "pageLabel": "102",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-101-eb-table-d6e-foot-massage-versus-routine-care"
    },
    {
      "level": 2,
      "title": "Health systems interventions to improve antenatal care utilization and quality",
      "number": "E",
      "page": 111,
      "pageLabel": "103",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-102-e-health-systems-interventions-to-improve-antena"
    },
    {
      "level": 2,
      "title": "Woman-held case notes",
      "number": "E.1",
      "page": 111,
      "pageLabel": "103",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-103-e1-woman-held-case-notes"
    },
    {
      "level": 3,
      "title": "EB Table E.1: Woman-held case notes versus control",
      "number": null,
      "page": 111,
      "pageLabel": "103",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-104-eb-table-e1-woman-held-case-notes-versus-control"
    },
    {
      "level": 2,
      "title": "Midwife-led continuity of care (MLCC)",
      "number": "E.2",
      "page": 112,
      "pageLabel": "104",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-105-e2-midwife-led-continuity-of-care-mlcc"
    },
    {
      "level": 3,
      "title": "EB Table E.2: MLCC versus other models",
      "number": null,
      "page": 112,
      "pageLabel": "104",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-106-eb-table-e2-mlcc-versus-other-models"
    },
    {
      "level": 3,
      "title": "Figure E.2: Additional analysis: MLCC model versus other models of care: satisfaction",
      "number": null,
      "page": 113,
      "pageLabel": "105",
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": "sec-107-figure-e2-additional-analysis-mlcc-model-versus"
    },
    {
      "level": 2,
      "title": "Group antenatal care (ANC)",
      "number": "E.3",
      "page": 114,
      "pageLabel": "106",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-108-e3-group-antenatal-care-anc"
    },
    {
      "level": 3,
      "title": "EB Table E.3: Group ANC versus individual ANC",
      "number": null,
      "page": 114,
      "pageLabel": "106",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-109-eb-table-e3-group-anc-versus-individual-anc"
    },
    {
      "level": 2,
      "title": "Community-based interventions to improve communication and support",
      "number": "E.4",
      "page": 116,
      "pageLabel": "108",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-110-e4-community-based-interventions-to-improve-comm"
    },
    {
      "level": 3,
      "title": "EB Table E.4: Community-based interventions (women’s groups, home visits or intervention packages with home visits and community mobilization) versus control",
      "number": null,
      "page": 116,
      "pageLabel": "108",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-111-eb-table-e4-community-based-interventions-womens"
    },
    {
      "level": 2,
      "title": "Antenatal care contact schedules",
      "number": "E.7",
      "page": 119,
      "pageLabel": "111",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-112-e7-antenatal-care-contact-schedules"
    },
    {
      "level": 3,
      "title": "EB Table E.7: Focused ANC (FANC) model (minimum of four visits) versus standard ANC model (minimum of eight visits)",
      "number": null,
      "page": 119,
      "pageLabel": "111",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-113-eb-table-e7-focused-anc-fanc-model-minimum-of-fo"
    },
    {
      "level": 2,
      "title": "Search strategies for the evidence base",
      "number": null,
      "page": 121,
      "pageLabel": "113",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-114-search-strategies-for-the-evidence-base"
    },
    {
      "level": 1,
      "title": "Search strategy to identify existing ANC guidelines",
      "number": "1",
      "page": 121,
      "pageLabel": "113",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-115-1-search-strategy-to-identify-existing-anc-guide"
    },
    {
      "level": 3,
      "title": "Search results",
      "number": null,
      "page": 121,
      "pageLabel": "113",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-116-search-results"
    },
    {
      "level": 1,
      "title": "Search strategy for qualitative meta-synthesis of women’s views",
      "number": "2",
      "page": 122,
      "pageLabel": "114",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-117-2-search-strategy-for-qualitative-meta-synthesis"
    },
    {
      "level": 3,
      "title": "Inclusion criteria",
      "number": null,
      "page": 122,
      "pageLabel": "114",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-118-inclusion-criteria"
    },
    {
      "level": 3,
      "title": "Search terms",
      "number": null,
      "page": 122,
      "pageLabel": "114",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-119-search-terms"
    },
    {
      "level": 1,
      "title": "Search strategy for qualitative meta-synthesis of health-care providers’ views",
      "number": "3",
      "page": 124,
      "pageLabel": "116",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-120-3-search-strategy-for-qualitative-meta-synthesis"
    },
    {
      "level": 3,
      "title": "Inclusion criteria",
      "number": null,
      "page": 124,
      "pageLabel": "116",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-121-inclusion-criteria"
    },
    {
      "level": 3,
      "title": "Search terms",
      "number": null,
      "page": 125,
      "pageLabel": "117",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-122-search-terms"
    },
    {
      "level": 3,
      "title": "Databases and other sources",
      "number": null,
      "page": 125,
      "pageLabel": "117",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-123-databases-and-other-sources"
    },
    {
      "level": 1,
      "title": "Search strategy for the review of factors affecting implementation of the WHO ANC guideline/recommendations (i.e. the 2016 WHO ANC model) – large-scale programme evaluation",
      "number": "4",
      "page": 126,
      "pageLabel": "118",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-124-4-search-strategy-for-the-review-of-factors-affe"
    },
    {
      "level": 3,
      "title": "Search strategy",
      "number": null,
      "page": 126,
      "pageLabel": "118",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Search strategy for indirect evidence for health systems interventions",
      "number": "5",
      "page": 128,
      "pageLabel": "120",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-125-5-search-strategy-for-indirect-evidence-for-heal"
    },
    {
      "level": 3,
      "title": "Background",
      "number": null,
      "page": 128,
      "pageLabel": "120",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-126-background"
    },
    {
      "level": 3,
      "title": "Methods",
      "number": null,
      "page": 128,
      "pageLabel": "120",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-127-methods"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 9,
      "labelStart": "i",
      "labelEnd": "1",
      "words": 1435,
      "summary": {
        "text": "Front matter for the Web supplement to the WHO recommendations on antenatal care for a positive pregnancy experience (evidence base), containing publication credits (editing, design, and layout by Green Ink), the complete table of contents across Sections A (Nutritional interventions A.1–A.10), B (Maternal and fetal assessment B.1–B.2), C (Preventive measures C.1–C.5), D (Interventions for common physiological symptoms D.1–D.6), E (Health systems interventions to improve antenatal care utilization and quality E.1–E.4, E.7), and Search strategies for the evidence base (1–5), plus a list of acronyms and abbreviations (ANC, CI, EB, Hb, MD, RCT, RR, UNIMMAP).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "supplements versus",
          "heading": false
        },
        {
          "term": "versus placebo",
          "heading": false
        },
        {
          "term": "anc versus",
          "heading": false
        },
        {
          "term": "acupuncture versus",
          "heading": false
        },
        {
          "term": "versus vitamin",
          "heading": false
        },
        {
          "term": "ultrasound versus",
          "heading": false
        },
        {
          "term": "ginger versus",
          "heading": false
        },
        {
          "term": "acupressure versus",
          "heading": false
        }
      ],
      "extract": "Running header Web supplement WHO recommendations on antenatal care for a positive pregnancy experience: evidence base* * The full guideline document and web annexes are available at: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/anc-positive-pregnancy-experience/en/ Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base ii Editing,",
      "extractCut": true,
      "blocks": [
        "library/9789241549912-websupplement-eng/blocks/prose-sec-front-matter"
      ]
    },
    {
      "id": "sec-000-a-nutritional-interventions",
      "number": "A",
      "title": "Nutritional interventions",
      "level": 2,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": "1",
      "labelEnd": "1",
      "words": 3,
      "summary": {
        "text": "Section heading introducing Part A (Nutritional interventions) of the WHO antenatal care guideline evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A. Nutritional interventions",
      "extractCut": false
    },
    {
      "id": "sec-001-a1-dietary-interventions",
      "number": "A.1",
      "title": "Dietary interventions",
      "level": 2,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": "1",
      "labelEnd": "1",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-002-eb-table-a11-all-diet-andor-physical-activityexe",
      "number": null,
      "title": "EB Table A.1.1: All diet and/or physical activity/exercise interventions versus control (standard or other care)",
      "level": 3,
      "pageStart": 9,
      "pageEnd": 16,
      "labelStart": "1",
      "labelEnd": "8",
      "words": 2766,
      "summary": {
        "text": "Evidence base table (EB Table A.1.1) from the Cochrane review by Muktabhant et al. (2015) comparing all diet and/or physical activity/exercise interventions during pregnancy against standard or other care. Presents GRADE quality assessments, study counts, event rates, relative risks, absolute effects, and certainty ratings across overall and intervention-subgroup analyses for pre-eclampsia (RR 0.95, high certainty), caesarean section (RR 0.95, low certainty; diet and exercise counselling RR 0.87, high certainty), excessive gestational weight gain (RR 0.80, high certainty, with consistent reductions across diet, counselling, and supervised/unsupervised exercise subgroups), preterm birth (RR 0.91, low certainty), macrosomia (> 4000 g; RR 0.93, moderate certainty), low birth weight (< 2500 g; RR 0.88, very low certainty), induction of labour (RR 1.06, moderate certainty), shoulder dystocia (RR 1.02, moderate certainty), neonatal hypoglycaemia (RR 0.95, moderate certainty), and neonatal respiratory distress (RR 0.47, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "exercise interventions",
          "heading": true
        },
        {
          "term": "activity exercise",
          "heading": true
        },
        {
          "term": "diet",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        }
      ],
      "extract": "Source: Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev. 2015;(6):CD007145. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations All diet and/ or exercise interventions Standard/other care Relative (95% CI) Absolute",
      "extractCut": true
    },
    {
      "id": "sec-003-figure-a11-additional-meta-analysis-effect-of-di",
      "number": null,
      "title": "Figure A.1.1: Additional meta-analysis: Effect of diet and/or exercise interventions versus control on gestational diabetes mellitus (GDM)",
      "level": 3,
      "pageStart": 16,
      "pageEnd": 18,
      "labelStart": "8",
      "labelEnd": "10",
      "words": 384,
      "summary": {
        "text": "Caption for Figure A.1.1 (additional meta-analysis on the effect of diet and/or exercise interventions versus control on gestational diabetes mellitus, not included in Muktabhant et al., 2015) followed by EB Table A.1.2 from Ota et al. (2015) evaluating antenatal energy and protein nutrition education versus no nutritional education or normal care. Reports GRADE evidence profiles for total gestational weight gain (MD 0.41 kg lower, very low certainty), small for gestational age (RR 0.97, low certainty), low birth weight (RR 0.04, low certainty), preterm birth (RR 0.46, very low certainty), stillbirth (RR 0.37, low certainty), and neonatal death (RR 1.28, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "versus control",
          "heading": true
        },
        {
          "term": "gestational",
          "heading": true
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "nutritional education",
          "heading": false
        }
      ],
      "extract": "Figure A.1.1: Additional meta-analysis: Effect of diet and/or exercise interventions versus control on gestational diabetes mellitus (GDM) (not included in the systematic review by Muktabhant et al., 2015 [see EB Table A.1.1]) Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base 9 EB Table A.1.2: Energy and protein nutrition education during pregnancy versus",
      "extractCut": true
    },
    {
      "id": "sec-004-eb-table-a13-energy-and-protein-dietary-suppleme",
      "number": null,
      "title": "EB Table A.1.3: Energy and protein dietary supplements versus control",
      "level": 3,
      "pageStart": 18,
      "pageEnd": 19,
      "labelStart": "10",
      "labelEnd": "11",
      "words": 325,
      "summary": {
        "text": "Evidence base table (EB Table A.1.3) from Ota et al. (2015) comparing balanced energy and protein dietary supplementation during pregnancy with control. Summarizes GRADE evidence showing reductions in small-for-gestational-age neonates (7 RCTs; RR 0.79, 95% CI 0.69–0.90; 36 fewer per 1000; moderate certainty) and stillbirth (5 RCTs; RR 0.60, 95% CI 0.39–0.94; 12 fewer per 1000; moderate certainty), alongside estimates for pre-eclampsia (RR 1.48, very low certainty), preterm birth (RR 0.96, moderate certainty), and neonatal death (RR 0.68, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "energy",
          "heading": true
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "protein",
          "heading": true
        }
      ],
      "extract": "EB Table A.1.3: Energy and protein dietary supplements versus control Source: Ota E, Hori H, Mori R, Tobe-Gai R, Farrar D. Antenatal dietary education and supplementation to increase energy and protein intake. Cochrane Database Syst Rev. 2015;(6):CD000032. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Balanced",
      "extractCut": true
    },
    {
      "id": "sec-005-eb-table-a14-high-protein-supplements-versus-con",
      "number": null,
      "title": "EB Table A.1.4: High-protein supplements versus control",
      "level": 3,
      "pageStart": 19,
      "pageEnd": 20,
      "labelStart": "11",
      "labelEnd": "12",
      "words": 245,
      "summary": {
        "text": "Evidence base table (EB Table A.1.4) from Ota et al. (2015) evaluating high-protein dietary supplementation versus control during pregnancy (1 RCT). Reports GRADE evidence demonstrating an increased risk of small-for-gestational-age neonates (RR 1.58, 95% CI 1.03–2.41; 68 more per 1000; high certainty), with uncertain effects on preterm birth (RR 1.14, moderate certainty), stillbirth (RR 0.81, low certainty), and neonatal death (RR 2.78, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "high-protein",
          "heading": true
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "fewer",
          "heading": false
        }
      ],
      "extract": "EB Table A.1.4: High-protein supplements versus control Source: Ota E, Hori H, Mori R, Tobe-Gai R, Farrar D. Antenatal dietary education and supplementation to increase energy and protein intake. Cochrane Database Syst Rev. 2015;(6):CD000032. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations High-protein supplementation",
      "extractCut": true
    },
    {
      "id": "sec-006-a2-iron-and-folic-acid-supplements",
      "number": "A.2",
      "title": "Iron and folic acid supplements",
      "level": 2,
      "pageStart": 20,
      "pageEnd": 20,
      "labelStart": "12",
      "labelEnd": "12",
      "words": 6,
      "summary": {
        "text": "Section heading introducing Section A.2 (Iron and folic acid supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.2. Iron and folic acid supplements",
      "extractCut": false
    },
    {
      "id": "sec-007-eb-table-a21-daily-iron-and-folic-acid-supplemen",
      "number": null,
      "title": "EB Table A.2.1: Daily iron and folic acid supplements versus control (supplements without iron or no treatment/placebo)",
      "level": 3,
      "pageStart": 20,
      "pageEnd": 24,
      "labelStart": "12",
      "labelEnd": "16",
      "words": 1280,
      "summary": {
        "text": "Evidence base table (EB Table A.2.1) from Peña-Rosas et al. (2015) comparing daily oral iron and folic acid supplementation during pregnancy against supplements without iron or placebo/no treatment. Presents GRADE ratings across maternal and perinatal outcomes, showing reduced maternal anaemia at term (RR 0.30, low certainty), higher maternal haemoglobin at or near term (MD 8.88 g/L higher, low certainty), increased high haemoglobin concentrations (> 130 g/L; RR 3.07, low certainty), reduced severe postpartum anaemia (RR 0.04, low certainty), reduced puerperal infection (RR 0.68, moderate certainty), reduced diarrhoea (RR 0.55, high certainty), reduced very preterm birth (< 34 weeks; RR 0.51, high certainty), and effects on maternal death, side-effects, antepartum/postpartum haemorrhage, transfusion, constipation, nausea, heartburn, vomiting, maternal satisfaction, placental abruption, pre-eclampsia, low birth weight (RR 0.84, low certainty), preterm birth (< 37 weeks; RR 0.93, high certainty), neonatal death, and congenital anomalies.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "iron",
          "heading": true
        },
        {
          "term": "supplements",
          "heading": true
        },
        {
          "term": "placebo",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        }
      ],
      "extract": "Source: Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(7):CD004736. Quality assessment No. of women Effect Certainty No. of studies Design Design limitations Inconsistency Indirectness Imprecision Other considerations Any supplements containing iron Same supplements without iron or no treatment/ placebo (no iron or placebo)",
      "extractCut": true
    },
    {
      "id": "sec-008-eb-table-a22-intermittent-iron-and-folic-acid-su",
      "number": null,
      "title": "EB Table A.2.2: Intermittent iron and folic acid supplements versus daily regimen with no iron",
      "level": 3,
      "pageStart": 24,
      "pageEnd": 27,
      "labelStart": "16",
      "labelEnd": "19",
      "words": 1068,
      "summary": {
        "text": "Evidence base table (EB Table A.2.2) from Peña-Rosas et al. (2015) comparing intermittent oral iron and folic acid regimens during pregnancy against daily iron supplementation regimens. Provides GRADE evidence profiles showing higher maternal anaemia at or near term (RR 1.66, moderate certainty), lower risk of high haemoglobin concentrations (> 130 g/L) in the second or third trimester (RR 0.53, moderate certainty), fewer overall side-effects (RR 0.56, very low certainty) and nausea (RR 0.60, moderate certainty), no events of severe anaemia (< 70 g/L; moderate certainty), and low- to very-low-certainty estimates for maternal anaemia at term, severe postpartum anaemia, mean haemoglobin concentration, antepartum haemorrhage, placental abruption, diarrhoea, constipation, heartburn, vomiting, preterm rupture of membranes, low birth weight (RR 0.82), preterm birth (RR 1.03), very preterm birth, and neonatal death.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "intermittent iron",
          "heading": true
        },
        {
          "term": "iron regimen",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "folic acid",
          "heading": true
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "acid supplements",
          "heading": true
        }
      ],
      "extract": "EB Table A.2.2: Intermittent iron and folic acid supplements versus daily regimen with no iron Source: Peña-Rosas JP, De-Regil LM, Gomez Malave H, Flores-Urrutia MC, Dowswell T. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(19):CD009997. Quality assessment No. of women Effect Certainty No. of studies Design Design limitations Inconsistency Indirectness Imprecision Other",
      "extractCut": true
    },
    {
      "id": "sec-009-a3-calcium-supplements",
      "number": "A.3",
      "title": "Calcium supplements",
      "level": 2,
      "pageStart": 27,
      "pageEnd": 27,
      "labelStart": "19",
      "labelEnd": "19",
      "words": 3,
      "summary": {
        "text": "Section heading introducing Section A.3 (Calcium supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.3. Calcium supplements",
      "extractCut": false
    },
    {
      "id": "sec-010-eb-table-a3-calcium-supplements-versus-placebo-o",
      "number": null,
      "title": "EB Table A.3: Calcium supplements versus placebo or no treatment",
      "level": 3,
      "pageStart": 27,
      "pageEnd": 30,
      "labelStart": "19",
      "labelEnd": "22",
      "words": 886,
      "summary": {
        "text": "Evidence base table (EB Table A.3) from Buppasiri et al. (2015) evaluating calcium supplementation (other than for preventing or treating hypertension) versus placebo or no treatment for maternal and infant outcomes. Reports GRADE evidence showing little or no difference in maternal anaemia (RR 1.04, high certainty), caesarean section (RR 0.99, high certainty), side-effects (RR 1.02, high certainty), urinary tract infection, maternal weight gain, maternal death, gall stones, urinary stones, renal colic, impaired renal function, low birth weight (RR 0.93, moderate certainty), stillbirth (RR 0.91, moderate certainty), and perinatal mortality (RR 0.87, low certainty), while high-dose calcium supplementation reduced preterm birth (12 RCTs; RR 0.81, 95% CI 0.66–0.99; moderate certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "calcium",
          "heading": true
        },
        {
          "term": "calcium supplementation",
          "heading": false
        }
      ],
      "extract": "Source: Buppasiri P, Lumbiganon P, Thinkhamrop J, Ngamjarus C, Laopaiboon M, Medley N. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes. Cochrane Database Syst Rev. 2015;(2):CD007079. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Calcium",
      "extractCut": true
    },
    {
      "id": "sec-011-a4-vitamin-a-supplements",
      "number": "A.4",
      "title": "Vitamin A supplements",
      "level": 2,
      "pageStart": 30,
      "pageEnd": 30,
      "labelStart": "22",
      "labelEnd": "22",
      "words": 4,
      "summary": {
        "text": "Section heading introducing Section A.4 (Vitamin A supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.4. Vitamin A supplements",
      "extractCut": false
    },
    {
      "id": "sec-012-eb-table-a4-vitamin-a-supplements-alone-versus-p",
      "number": null,
      "title": "EB Table A.4: Vitamin A supplements alone versus placebo or no treatment",
      "level": 3,
      "pageStart": 30,
      "pageEnd": 32,
      "labelStart": "22",
      "labelEnd": "24",
      "words": 469,
      "summary": {
        "text": "Evidence base table (EB Table A.4) from McCauley et al. (2015) comparing antenatal vitamin A supplementation alone against placebo or no treatment. Summarizes GRADE evidence indicating reductions in maternal anaemia (3 RCTs; RR 0.64, moderate certainty), maternal infection (5 RCTs; RR 0.45, low certainty), and maternal night blindness (2 RCTs; RR 0.79, low certainty), with no clear effect on perinatal mortality (RR 1.01, high certainty), neonatal mortality (RR 0.97, high certainty), stillbirth (RR 1.04, high certainty), maternal death (RR 0.88, moderate certainty), low birth weight (RR 1.02, moderate certainty), or preterm birth (RR 0.98, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "vitamin alone",
          "heading": true
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "bias serious",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        }
      ],
      "extract": "Source: McCauley ME, van den Broek N, Dou L, Othman M. Vitamin A supplementation during pregnancy for maternal and newborn outcomes. Cochrane Database Syst Rev. 2015;(10):CD008666. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Vitamin A alone Control (placebo or no treatment) Relative (95% CI) Absolute Maternal anaemia",
      "extractCut": true
    },
    {
      "id": "sec-013-a5-zinc-supplements",
      "number": "A.5",
      "title": "Zinc supplements",
      "level": 2,
      "pageStart": 32,
      "pageEnd": 32,
      "labelStart": "24",
      "labelEnd": "24",
      "words": 3,
      "summary": {
        "text": "Section heading introducing Section A.5 (Zinc supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.5. Zinc supplements",
      "extractCut": false
    },
    {
      "id": "sec-014-eb-table-a5-zinc-supplements-versus-no-intervent",
      "number": null,
      "title": "EB Table A.5: Zinc supplements versus no intervention or placebo",
      "level": 3,
      "pageStart": 32,
      "pageEnd": 34,
      "labelStart": "24",
      "labelEnd": "26",
      "words": 601,
      "summary": {
        "text": "Evidence base table (EB Table A.5) from Ota et al. (2015) evaluating zinc supplementation versus placebo or no intervention during pregnancy. Reports GRADE evidence showing a reduction in preterm birth (16 RCTs; RR 0.86, 95% CI 0.76–0.97; 18 fewer per 1000; low certainty), with no clear difference across maternal infection (RR 1.06, moderate certainty), pregnancy hypertension or pre-eclampsia (RR 0.83, very low certainty), caesarean section (RR 0.95, very low certainty), instrumental vaginal birth (RR 1.12, very low certainty), smell or taste dysfunction side-effects, neonatal infection (RR 0.17, low certainty), small for gestational age (RR 1.02, low certainty), low birth weight (RR 0.93, low certainty), or congenital malformation (RR 0.67, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious reporting",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "zinc",
          "heading": true
        }
      ],
      "extract": "Source: Ota E, Mori R, Middleton P, Tobe-Gai R, Mahomed K, Miyazaki C, Bhutta ZA. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev. 2015;(2):CD000230. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Vitamin A alone Control (placebo or no treatment) Relative (95% CI) Absolute Any",
      "extractCut": true
    },
    {
      "id": "sec-015-a6-multiple-micronutrient-mmn-supplements",
      "number": "A.6",
      "title": "Multiple micronutrient (MMN) supplements",
      "level": 2,
      "pageStart": 34,
      "pageEnd": 34,
      "labelStart": "26",
      "labelEnd": "26",
      "words": 5,
      "summary": {
        "text": "Section heading introducing Section A.6 (Multiple micronutrient (MMN) supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.6. Multiple micronutrient (MMN) supplements",
      "extractCut": false
    },
    {
      "id": "sec-016-eb-table-a6-multiple-micronutrient-supplements-v",
      "number": null,
      "title": "EB Table A.6: Multiple micronutrient supplements versus iron (with or without folic acid)1",
      "level": 3,
      "pageStart": 34,
      "pageEnd": 36,
      "labelStart": "26",
      "labelEnd": "28",
      "words": 564,
      "summary": {
        "text": "Evidence base table (EB Table A.6) from Haider and Bhutta (2015) comparing multiple micronutrient (MMN) supplements containing 13–15 micronutrients against iron supplements (with or without folic acid) during pregnancy. Reports GRADE ratings showing a reduction in low birth weight (14 RCTs; RR 0.88, 95% CI 0.85–0.91; high certainty) and a borderline reduction in small for gestational age (13 RCTs; RR 0.98, 95% CI 0.96–1.00; moderate certainty), alongside little or no difference in maternal third-trimester anaemia (RR 0.98, high certainty), preterm birth (RR 0.95, high certainty), caesarean section (RR 1.03, moderate certainty), perinatal mortality (RR 1.00, moderate certainty), stillbirths (RR 0.97, moderate certainty), neonatal mortality (RR 0.99, moderate certainty), maternal mortality (RR 0.97, low certainty), and congenital anomalies (RR 0.99, low certainty), plus an introductory note on the additional iron-dose subgroup and UNIMMAP meta-analyses.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "folic acid",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "versus iron",
          "heading": true
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        }
      ],
      "extract": "Source: Haider BA, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2015;(11):CD004905. Quality assessment No. of women1 Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations 13–15 micronutrients Iron (with or without folic acid) Relative (95% CI) Maternal anaemia (third trimester Hb < 110 g/L) 5",
      "extractCut": true
    },
    {
      "id": "sec-017-i-subgroup-analyses-grouping-trials-according-to",
      "number": null,
      "title": "i. Subgroup analyses grouping trials according to dose of iron in the control group",
      "level": 3,
      "pageStart": 36,
      "pageEnd": 47,
      "labelStart": "28",
      "labelEnd": "39",
      "words": 484,
      "summary": {
        "text": "Section headings and figure captions (pages 28–39) for the additional subgroup meta-analyses of multiple micronutrient (MMN) supplementation trials grouped by the iron dose in the control arm (60 mg, 30 mg, or not stated, with 0.4 mg folic acid unless footnoted), covering maternal anaemia (1), caesarean section (2), maternal mortality (3), small for gestational age (4 and exploratory analysis 4b restricted to 60 mg or 30 mg iron plus 0.4 mg folic acid controls), low birth weight (5), preterm birth (6), congenital anomalies (7), perinatal mortality (8), stillbirth (9), and neonatal mortality (10 and exploratory analysis 10b).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "grouping trials",
          "heading": true
        },
        {
          "term": "analyses grouping",
          "heading": true
        },
        {
          "term": "subgroup analyses",
          "heading": true
        },
        {
          "term": "trials according",
          "heading": true
        },
        {
          "term": "iron",
          "heading": true
        },
        {
          "term": "control group",
          "heading": true
        },
        {
          "term": "dose",
          "heading": true
        },
        {
          "term": "web supplement",
          "heading": false
        }
      ],
      "extract": "1. Maternal anaemia 2 Folic acid is 0.4 mg in the control group for all trials unless footnoted. Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base 29 i. Subgroup analyses grouping trials according to dose of iron in the control group (60 mg, 30 mg or not stated) (continued) 2. Caesarean section Web supplement: WHO recommendations on antenatal care for a positive",
      "extractCut": true
    },
    {
      "id": "sec-018-ii-meta-analyses-of-trials-evaluating-unimmap-su",
      "number": "ii",
      "title": "Meta-analyses of trials evaluating UNIMMAP supplements with trials grouped according to dose of iron in the control group",
      "level": 1,
      "pageStart": 47,
      "pageEnd": 56,
      "labelStart": "39",
      "labelEnd": "48",
      "words": 428,
      "summary": {
        "text": "Section headings and figure captions (pages 39–47) for the additional meta-analyses of trials specifically evaluating the United Nations international multiple micronutrient preparation (UNIMMAP) supplement, grouped by the control group iron dose (60 mg, 30 mg, or not stated, with 0.4 mg folic acid unless footnoted), across maternal anaemia (1), caesarean section (2), maternal mortality (3), small for gestational age (4), low birth weight (5), preterm birth (6), congenital anomalies (7), perinatal mortality (8), stillbirth (9), and neonatal mortality (10a and exploratory analysis 10b restricted to 60 mg or 30 mg iron plus 0.4 mg folic acid controls).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "unimmap supplements",
          "heading": true
        },
        {
          "term": "evaluating unimmap",
          "heading": true
        },
        {
          "term": "trials grouped",
          "heading": true
        },
        {
          "term": "grouped according",
          "heading": true
        },
        {
          "term": "iron",
          "heading": true
        },
        {
          "term": "control group",
          "heading": true
        },
        {
          "term": "meta-analyses",
          "heading": true
        },
        {
          "term": "dose",
          "heading": true
        }
      ],
      "extract": "group (60 mg, 30 mg or not stated)3 1. Maternal anaemia 3 Folic acid is 0.4 mg in the control group for all trials unless footnoted. Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base 40 ii. Meta-analyses of trials evaluating UNIMMAP supplements with trials grouped according to dose of iron in the control group (60 mg, 30 mg or not stated) (continued) 2.",
      "extractCut": true
    },
    {
      "id": "sec-019-a7-vitamin-b6-pyridoxine-supplements",
      "number": "A.7",
      "title": "Vitamin B6 (pyridoxine) supplements",
      "level": 2,
      "pageStart": 56,
      "pageEnd": 56,
      "labelStart": "48",
      "labelEnd": "48",
      "words": 5,
      "summary": {
        "text": "Section heading introducing Section A.7 (Vitamin B6 (pyridoxine) supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.7. Vitamin B6 (pyridoxine) supplements",
      "extractCut": false
    },
    {
      "id": "sec-020-eb-table-a7-vitamin-b6-pyridoxine-supplements-ve",
      "number": null,
      "title": "EB Table A.7: Vitamin B6 (pyridoxine) supplements versus control",
      "level": 3,
      "pageStart": 56,
      "pageEnd": 57,
      "labelStart": "48",
      "labelEnd": "49",
      "words": 180,
      "summary": {
        "text": "Evidence base table (EB Table A.7) from Salam et al. (2015) comparing antenatal vitamin B6 (pyridoxine) supplementation against control. Reports GRADE evidence for pre-eclampsia with antenatal oral pyridoxine tablets (2 RCTs; RR 1.71, 95% CI 0.85–3.45; low certainty) and antenatal pyridoxine lozenges (1 RCT; RR 1.43, 95% CI 0.64–3.22; very low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pyridoxine",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "pre-eclampsia antenatal",
          "heading": false
        }
      ],
      "extract": "Source: Salam RA, Zuberi NF, Bhutta ZA. Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes. Cochrane Database Syst Rev. 2015;(6):CD000179. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Pyridoxine (B6) Control Relative (95% CI) Absolute Pre-eclampsia – antenatal oral",
      "extractCut": true
    },
    {
      "id": "sec-021-a8-vitamin-e-and-c-supplements",
      "number": "A.8",
      "title": "Vitamin E and C supplements",
      "level": 2,
      "pageStart": 57,
      "pageEnd": 57,
      "labelStart": "49",
      "labelEnd": "49",
      "words": 6,
      "summary": {
        "text": "Section heading introducing Section A.8 (Vitamin E and C supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.8. Vitamin E and C supplements",
      "extractCut": false
    },
    {
      "id": "sec-022-eb-table-a8a-vitamin-e-and-c-supplementation-ver",
      "number": null,
      "title": "EB Table A.8a: Vitamin E and C supplementation versus placebo or no treatment",
      "level": 3,
      "pageStart": 57,
      "pageEnd": 60,
      "labelStart": "49",
      "labelEnd": "52",
      "words": 929,
      "summary": {
        "text": "Evidence base table (EB Table A.8a) from Rumbold et al. (2015) comparing combined vitamin E and C supplementation during pregnancy against placebo or no treatment. Presents GRADE evidence showing increased risks of abdominal pain (1 RCT; RR 1.66, high certainty) and term prelabour rupture of membranes (PROM >= 37 weeks; 2 RCTs; RR 1.77, high certainty), a reduction in placental abruption (7 RCTs; RR 0.64, moderate certainty), and no clear benefit for pre-eclampsia (14 RCTs; RR 0.91, moderate certainty), eclampsia (RR 1.67, moderate certainty), caesarean section (RR 1.02, high certainty), induction of labour, maternal death, antepartum haemorrhage, overall side-effects, small for gestational age (RR 0.98, high certainty), preterm birth (RR 0.98, moderate certainty), congenital malformations, stillbirth, neonatal death, perinatal death, or preterm PROM (RR 1.27, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "supplementation versus",
          "heading": true
        },
        {
          "term": "versus placebo",
          "heading": true
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "serious reporting",
          "heading": false
        }
      ],
      "extract": "Source: Rumbold A, Ota E, Hori H, Miyazaki C, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev. 2015;(9):CD004069. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Any vitamin E and C supplementation Control (placebo or no treatment) Relative (95% CI) Absolute Pre-eclampsia 14 randomized",
      "extractCut": true
    },
    {
      "id": "sec-023-eb-table-a8b-vitamin-c-supplementation-alone-ver",
      "number": null,
      "title": "EB Table A.8b: Vitamin C supplementation alone versus placebo or no treatment",
      "level": 3,
      "pageStart": 60,
      "pageEnd": 61,
      "labelStart": "52",
      "labelEnd": "53",
      "words": 212,
      "summary": {
        "text": "Evidence base table (EB Table A.8b) from Rumbold et al. (2015) evaluating vitamin C supplementation alone versus placebo or no treatment during pregnancy. Reports GRADE evidence for overall prelabour rupture of membranes (6 RCTs; RR 0.63, 95% CI 0.48–0.83; moderate certainty), preterm PROM (5 RCTs; RR 0.66, 95% CI 0.48–0.91; moderate certainty), and term PROM (1 RCT; RR 0.55, 95% CI 0.32–0.94; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vitamin supplementation",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "imprecision none",
          "heading": false
        }
      ],
      "extract": "EB Table A.8b: Vitamin C supplementation alone versus placebo or no treatment Source: Rumbold A, Ota E, Hori H, Miyazaki C, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev. 2015;(9):CD004069. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Vitamin C alone Placebo or no treatment Relative",
      "extractCut": true
    },
    {
      "id": "sec-024-a9-vitamin-d-supplements",
      "number": "A.9",
      "title": "Vitamin D supplements",
      "level": 2,
      "pageStart": 61,
      "pageEnd": 61,
      "labelStart": "53",
      "labelEnd": "53",
      "words": 4,
      "summary": {
        "text": "Section heading introducing Section A.9 (Vitamin D supplements) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.9. Vitamin D supplements",
      "extractCut": false
    },
    {
      "id": "sec-025-eb-table-a9-vitamin-d-supplementation-alone-or-w",
      "number": null,
      "title": "EB Table A.9: Vitamin D supplementation alone or with calcium versus placebo or no treatment",
      "level": 3,
      "pageStart": 61,
      "pageEnd": 63,
      "labelStart": "53",
      "labelEnd": "55",
      "words": 664,
      "summary": {
        "text": "Evidence base table (EB Table A.9) from De-Regil et al. (2016) evaluating antenatal vitamin D supplementation alone or combined with calcium versus placebo or no treatment. For vitamin D alone, reports GRADE evidence of low certainty for reductions in preterm birth (3 RCTs; RR 0.36, 95% CI 0.14–0.93) and low birth weight (3 RCTs; RR 0.40, 95% CI 0.24–0.67), alongside low- or very-low-certainty estimates for pre-eclampsia (RR 0.52), gestational diabetes (RR 0.43), caesarean section (RR 0.95), maternal death, stillbirth (RR 0.35), and neonatal death (RR 0.27). For vitamin D plus calcium, shows reduced pre-eclampsia (3 RCTs; RR 0.51, 95% CI 0.32–0.80; moderate certainty) but increased preterm birth (3 RCTs; RR 1.57, 95% CI 1.02–2.43; moderate certainty), with uncertain effects on gestational diabetes and neonatal death.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vitamin supplementation",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "fewer",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        },
        {
          "term": "data come",
          "heading": false
        }
      ],
      "extract": "Source: De-Regil LM, Palacios C, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016;(1):CD008873. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Intervention Control Relative (95% CI) Absolute Vitamin D supplementation alone versus placebo or no treatment",
      "extractCut": true
    },
    {
      "id": "sec-026-a10-restricting-caffeine-intake",
      "number": "A.10",
      "title": "Restricting caffeine intake",
      "level": 2,
      "pageStart": 63,
      "pageEnd": 63,
      "labelStart": "55",
      "labelEnd": "55",
      "words": 4,
      "summary": {
        "text": "Section heading introducing Section A.10 (Restricting caffeine intake) under Nutritional interventions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "A.10. Restricting caffeine intake",
      "extractCut": false
    },
    {
      "id": "sec-027-eb-table-a10a-caffeinated-coffee-versus-decaffei",
      "number": null,
      "title": "EB Table A.10a: Caffeinated coffee versus decaffeinated coffee",
      "level": 3,
      "pageStart": 63,
      "pageEnd": 64,
      "labelStart": "55",
      "labelEnd": "56",
      "words": 161,
      "summary": {
        "text": "Evidence base table (EB Table A.10a) from the Cochrane review by Jahanfar and Jaafar (2015) comparing caffeinated coffee against decaffeinated coffee during pregnancy (1 RCT). Reports moderate-certainty GRADE evidence showing no clear difference in preterm birth (RR 0.81, 95% CI 0.48–1.37) or small for gestational age (RR 0.97, 95% CI 0.57–1.64), downgraded for indirectness (only coffee restricted) and wide confidence intervals.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "caffeinated coffee",
          "heading": true
        },
        {
          "term": "inconsistency serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "caffeine intake",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        }
      ],
      "extract": "Source: Jahanfar S, Jaafar SH. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. Cochrane Database Syst Rev. 2015;(6):CD006965. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Caffeinated coffee Decaffeinated coffee Relative (95% CI) Absolute Preterm birth 1 randomized trials no",
      "extractCut": true
    },
    {
      "id": "sec-028-eb-table-a10b-non-randomized-evidence-of-effect",
      "number": null,
      "title": "EB Table A.10b: Non-randomized evidence of effect of caffeine on low birth weight – 1",
      "level": 3,
      "pageStart": 64,
      "pageEnd": 65,
      "labelStart": "56",
      "labelEnd": "57",
      "words": 324,
      "summary": {
        "text": "Evidence base tables (EB Table A.10b – 1 and 2) summarizing non-randomized observational meta-analyses on maternal caffeine intake during pregnancy and low birth weight. Part 1 (Chen et al., 2014) shows a dose-dependent increase in low birth weight risk across low (RR 1.13, moderate certainty), moderate (RR 1.38, low certainty), and high (RR 1.60, very low certainty) caffeine intake versus very low or no intake; Part 2 (Rhee et al., 2015; 12 observational studies) likewise shows higher odds of low birth weight for higher versus lower caffeine intake (OR 1.38, 95% CI 1.10–1.73; moderate certainty, upgraded for linear dose–response gradient).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "caffeine",
          "heading": true
        },
        {
          "term": "birth weight",
          "heading": true
        },
        {
          "term": "caffeine intake",
          "heading": false
        },
        {
          "term": "intake observational",
          "heading": false
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "maternal caffeine",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        }
      ],
      "extract": "EB Table A.10b: Non-randomized evidence of effect of caffeine on low birth weight – 1 Source: Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM. Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis. BMC Med. 2014;12:174. doi:10.1186/s12916-014-0174-6. Quality assessment Effect Certainty No. of studies Design Risk of bias",
      "extractCut": true
    },
    {
      "id": "sec-029-eb-table-a10c-non-randomized-evidence-of-effect",
      "number": null,
      "title": "EB Table A.10c: Non-randomized evidence of effect of caffeine on pregnancy loss – 1",
      "level": 3,
      "pageStart": 65,
      "pageEnd": 67,
      "labelStart": "57",
      "labelEnd": "59",
      "words": 531,
      "summary": {
        "text": "Evidence base tables (EB Table A.10c – 1 and 2) presenting non-randomized observational meta-analyses of maternal caffeine consumption and pregnancy loss. Part 1 (Chen et al., 2016) reports very-low-certainty odds ratios across low (OR 1.02), moderate (OR 1.16), high (OR 1.40), and very high (OR 1.72) caffeine intake versus very low/no intake due to funnel plot asymmetry; Part 2 (Li et al., 2015) reports moderate-certainty evidence (upgraded for a linear 19% risk increase per 150 mg/day caffeine) showing elevated pregnancy loss for any caffeine intake (18 studies; OR 1.32, 95% CI 1.24–1.40), moderate intake (OR 1.28), and high intake (OR 1.60), but not low intake (OR 1.04).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "caffeine",
          "heading": true
        },
        {
          "term": "pregnancy loss",
          "heading": true
        },
        {
          "term": "caffeine intake",
          "heading": false
        },
        {
          "term": "moderate caffeine",
          "heading": false
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "intake observational",
          "heading": false
        }
      ],
      "extract": "EB Table A.10c: Non-randomized evidence of effect of caffeine on pregnancy loss – 1 Source: Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM. Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose- response meta-analysis of prospective studies. Public Health Nutr. 2016:19(7):1233–44. doi:10.1017/S1368980015002463. Quality assessment Effect Certainty No. of studies",
      "extractCut": true
    },
    {
      "id": "sec-030-b-maternal-and-fetal-assessment",
      "number": "B",
      "title": "Maternal and fetal assessment",
      "level": 2,
      "pageStart": 67,
      "pageEnd": 67,
      "labelStart": "59",
      "labelEnd": "59",
      "words": 5,
      "summary": {
        "text": "Section heading introducing Part B (Maternal and fetal assessment) of the WHO antenatal care guideline evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "B. Maternal and fetal assessment",
      "extractCut": false
    },
    {
      "id": "sec-031-b1-maternal-assessment",
      "number": "B.1",
      "title": "Maternal assessment",
      "level": 2,
      "pageStart": 67,
      "pageEnd": 67,
      "labelStart": "59",
      "labelEnd": "59",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-032-eb-table-b11a-anaemia-test-accuracy-haemoglobino",
      "number": null,
      "title": "EB Table B.1.1a: Anaemia (test accuracy): haemoglobinometer method for diagnosing anaemia (Hb < 11 g/dL) in pregnancy",
      "level": 3,
      "pageStart": 67,
      "pageEnd": 67,
      "labelStart": "59",
      "labelEnd": "59",
      "words": 162,
      "summary": {
        "text": "Evidence base table (EB Table B.1.1a) from the systematic review by Sobhy, Rogozinska, and Khan (2016) evaluating the diagnostic test accuracy of on-site haemoglobinometer testing for detecting anaemia (Hb < 11 g/dL) in pregnancy (1 study; 157 women with anaemia, 514 without). Reports a pooled sensitivity of 0.85 (95% CI 0.79–0.90) and pooled specificity of 0.80 (95% CI 0.76–0.83), with moderate certainty of evidence and anticipated true/false positive and negative counts per 1000 women tested at 24%, 42%, and 57% anaemia prevalence.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "anaemia",
          "heading": true
        },
        {
          "term": "having anaemia",
          "heading": false
        },
        {
          "term": "women",
          "heading": false
        },
        {
          "term": "sobhy",
          "heading": false
        }
      ],
      "extract": "Source: Sobhy S, Rogozinska E, Khan KS. Accuracy of on-site tests to detect anaemia in antenatal care: a systematic review. BJOG. 2016 (in press). Pooled sensitivity: 0.85 (95% CI: 0.79–0.90); pooled specificity: 0.80 (95% CI: 0.76–0.83). Test result (anaemia is defined as Hb < 11 g/dL) No. of results per 1000 women tested (95% CI) No. of participants (studies) Certainty Prevalence 24% Prevalence 42% Prevalence 57%",
      "extractCut": true
    },
    {
      "id": "sec-033-eb-table-b11b-anaemia-test-accuracy-hb-colour-sc",
      "number": null,
      "title": "EB Table B.1.1b: Anaemia (test accuracy): Hb Colour Scale method for diagnosing anaemia (Hb < 11 g/dL) in pregnancy",
      "level": 3,
      "pageStart": 67,
      "pageEnd": 68,
      "labelStart": "59",
      "labelEnd": "60",
      "words": 176,
      "summary": {
        "text": "Evidence base table (EB Table B.1.1b) from Sobhy, Rogozinska, and Khan (2016) assessing the diagnostic accuracy of the Haemoglobin (Hb) Colour Scale method for diagnosing anaemia (Hb < 11 g/dL) during pregnancy. Reports a pooled sensitivity of 0.75 (95% CI 0.71–0.80) and pooled specificity of 0.47 (95% CI 0.41–0.53) at moderate certainty, alongside illustrative true/false positive and negative counts per 1000 women across 24%, 42%, and 57% pre-test prevalence levels.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "anaemia",
          "heading": true
        },
        {
          "term": "having anaemia",
          "heading": false
        },
        {
          "term": "antenatal care",
          "heading": false
        },
        {
          "term": "women",
          "heading": false
        }
      ],
      "extract": "Source: Sobhy S, Rogozinska E, Khan KS. Accuracy of on-site tests to detect anaemia in antenatal care: a systematic review. BJOG. 2016 (in press). Pooled sensitivity: 0.75 (95% CI: 0.71–0.80); pooled specificity: 0.47 (95% CI: 0.41–0.53). Test result (anaemia is defined as Hb < 11 g/dL) No. of results per 1000 women tested (95% CI) No. of participants (studies) Certainty Prevalence 24% Prevalence 42% Prevalence 57%",
      "extractCut": true
    },
    {
      "id": "sec-034-eb-table-b12a-asymptomatic-bacteriuria-asb-dipst",
      "number": null,
      "title": "EB Table B.1.2a: Asymptomatic bacteriuria (ASB): dipstick (nitrites or leukocytes) for diagnosing ASB in pregnancy",
      "level": 3,
      "pageStart": 68,
      "pageEnd": 68,
      "labelStart": "60",
      "labelEnd": "60",
      "words": 188,
      "summary": {
        "text": "Evidence base table (EB Table B.1.2a) from Rogozinska et al. (2016) evaluating the diagnostic test accuracy of on-site urine dipstick testing (nitrites or leukocytes) for detecting asymptomatic bacteriuria (ASB) in pregnancy (7 studies; 603 women with ASB, 5087 without). Reports a pooled sensitivity of 0.73 (95% CI 0.59–0.83) and pooled specificity of 0.89 (95% CI 0.79–0.94) with very low certainty due to risk of bias, inconsistency, and imprecision, modelling true/false positive and negative rates per 1000 women at 3%, 9%, and 19% ASB prevalence.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "asb",
          "heading": true
        },
        {
          "term": "asymptomatic bacteriuria",
          "heading": true
        },
        {
          "term": "having asb",
          "heading": false
        },
        {
          "term": "leukocytes",
          "heading": true
        },
        {
          "term": "nitrites",
          "heading": true
        }
      ],
      "extract": "EB Table B.1.2a: Asymptomatic bacteriuria (ASB): dipstick (nitrites or leukocytes) for diagnosing ASB in pregnancy Source: Rogozinska E, Formina S, Zamora J, Mignini L, Khan KS. Accuracy of on-site tests to detect asymptomatic bacteriuria in pregnancy: a systematic review and meta-analysis. Obstet Gynecol. 2016;128(3):495–503. doi:10.1097/AOG.0000000000001597. Pooled sensitivity: 0.73 (95% CI: 0.59–0.83); pooled",
      "extractCut": true
    },
    {
      "id": "sec-035-eb-table-b12b-asymptomatic-bacteriuria-asb-gram",
      "number": null,
      "title": "EB Table B.1.2b: Asymptomatic bacteriuria (ASB): Gram staining for diagnosing ASB in pregnancy",
      "level": 3,
      "pageStart": 68,
      "pageEnd": 69,
      "labelStart": "60",
      "labelEnd": "61",
      "words": 164,
      "summary": {
        "text": "Evidence base table (EB Table B.1.2b) from Rogozinska et al. (2016) assessing the diagnostic accuracy of on-site Gram staining for diagnosing asymptomatic bacteriuria (ASB) in pregnancy (4 studies; 156 women with ASB, 1748 without). Reports a pooled sensitivity of 0.86 (95% CI 0.80–0.91) and pooled specificity of 0.97 (95% CI 0.93–0.99) with very low certainty of evidence, along with expected true/false positive and negative results per 1000 women tested at 3%, 9%, and 19% prevalence.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "asb",
          "heading": true
        },
        {
          "term": "having asb",
          "heading": false
        },
        {
          "term": "women",
          "heading": false
        },
        {
          "term": "pregnancy",
          "heading": true
        }
      ],
      "extract": "Pooled sensitivity: 0.86 (95% CI: 0.80–0.91); pooled specificity: 0.97 (95% CI: 0.93–0.99). Test result No. of results per 1000 women tested (95% CI) No. of participants (studies) Certainty Prevalence 3% Prevalence 9% Prevalence 19% True positives (women with ASB) 25 (23 to 27) 76 (68 to 81) 160 (143 to 171) 156 (4) VERY LOW 1 ,2,3 False negatives (women incorrectly classified as not having ASB) 5 (3 to 7) 14 (9 to",
      "extractCut": true
    },
    {
      "id": "sec-036-eb-table-b13-intimate-partner-violence-ipv-scree",
      "number": null,
      "title": "EB Table B.1.3: Intimate partner violence (IPV): screening women for IPV",
      "level": 3,
      "pageStart": 69,
      "pageEnd": 70,
      "labelStart": "61",
      "labelEnd": "62",
      "words": 112,
      "summary": {
        "text": "Evidence base table (EB Table B.1.3) evaluating universal antenatal screening for intimate partner violence (IPV) compared with usual antenatal care (2 RCTs, 663 participants). Shows that universal screening substantially increases identification of IPV (RR 4.28, 95% CI 1.77–10.36; 57 more per 1000 from a baseline of 17 per 1000; low certainty due to high risk of bias).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ipv",
          "heading": true
        },
        {
          "term": "intimate",
          "heading": true
        },
        {
          "term": "screening",
          "heading": true
        },
        {
          "term": "antenatal care",
          "heading": false
        }
      ],
      "extract": "EB Table B.1.3: Intimate partner violence (IPV): screening women for IPV Source: Rogozinska E, Formina S, Zamora J, Mignini L, Khan KS. Accuracy of on-site tests to detect asymptomatic bacteriuria in pregnancy: a systematic review and meta-analysis. Obstet Gynecol. 2016;128(3):495–503. doi:10.1097/AOG.0000000000001597. Outcome No. of participants (studies) Anticipated absolute effects Relative effect (95% CI)",
      "extractCut": true
    },
    {
      "id": "sec-037-b2-fetal-assessment",
      "number": "B.2",
      "title": "Fetal assessment",
      "level": 2,
      "pageStart": 70,
      "pageEnd": 71,
      "labelStart": "62",
      "labelEnd": "63",
      "words": 299,
      "summary": {
        "text": "Section B.2 heading (Fetal assessment) and EB Table B.2.1 from Mangesi et al. (2015) comparing routine daily fetal movement counting with usual practice (mixed or undefined counting; 1 RCT, 1076 participants). Reports low- to very-low-certainty GRADE evidence showing slightly lower maternal anxiety scores (1013 women; SMD -0.22, 95% CI -0.35 to -0.10; low certainty), no perinatal deaths in either group, and uncertain effects on caesarean section (RR 0.93), assisted vaginal birth (RR 1.04), preterm birth (RR 0.81), and low birth weight (RR 0.98).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "fetal",
          "heading": true
        },
        {
          "term": "fetal movement",
          "heading": false
        },
        {
          "term": "movement counting",
          "heading": false
        },
        {
          "term": "undefined fetal",
          "heading": false
        },
        {
          "term": "rct",
          "heading": false
        },
        {
          "term": "fewer",
          "heading": false
        }
      ],
      "extract": "B.2. Fetal assessment EB Table B.2.1: Routine daily fetal movement counting versus usual practice (mixed or undefined fetal movement counting) Source: Mangesi L, Hofmeyr GJ, Smith V, Smyth RMD. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev. 2015;(10):CD004909. Outcome No. of participants (studies) Anticipated absolute effects* Relative effect (95% CI) Certainty Risk with mixed",
      "extractCut": true
    },
    {
      "id": "sec-038-eb-table-b22-symphysis-fundal-height-sfh-measure",
      "number": null,
      "title": "EB Table B.2.2: Symphysis-fundal height (SFH) measurement versus clinical palpation",
      "level": 3,
      "pageStart": 71,
      "pageEnd": 71,
      "labelStart": "63",
      "labelEnd": "63",
      "words": 211,
      "summary": {
        "text": "Evidence base table (EB Table B.2.2) from Robert Peter et al. (2015) comparing tape measurement of symphysis-fundal height (SFH) against clinical abdominal palpation for detecting abnormal fetal growth (1 RCT, 1639 participants). Reports GRADE evidence showing no clear difference in small for gestational age (RR 1.32, 95% CI 0.92–1.90; moderate certainty), caesarean section (RR 0.72, low certainty), induction of labour (RR 0.84, low certainty), or perinatal mortality (RR 1.25, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "clinical palpation",
          "heading": true
        },
        {
          "term": "sfh",
          "heading": true
        },
        {
          "term": "height",
          "heading": true
        },
        {
          "term": "measurement",
          "heading": true
        },
        {
          "term": "rct",
          "heading": false
        }
      ],
      "extract": "EB Table B.2.2: Symphysis-fundal height (SFH) measurement versus clinical palpation Source: Robert Peter J, Ho JJ, Valliapan J, Sivasangari S. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth. Cochrane Database Syst Rev. 2015;(9):CD008136. Outcome No. of participants (studies) Anticipated absolute effects* Relative effect (95% CI) Certainty Risk with clinical palpation Risk",
      "extractCut": true
    },
    {
      "id": "sec-039-eb-table-b23-routine-antenatal-cardiotocography",
      "number": null,
      "title": "EB Table B.2.3: Routine antenatal cardiotocography (CTG) versus no routine antenatal CTG",
      "level": 3,
      "pageStart": 71,
      "pageEnd": 72,
      "labelStart": "63",
      "labelEnd": "64",
      "words": 43,
      "summary": {
        "text": "Evidence base entry (EB Table B.2.3) citing the Cochrane review by Grivell et al. (2015) on antenatal cardiotocography (CTG) for fetal assessment and noting that there was no direct randomized evidence on the effects of routine antenatal CTG versus no routine antenatal CTG in normal pregnancy.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "cardiotocography",
          "heading": true
        },
        {
          "term": "antenatal",
          "heading": true
        },
        {
          "term": "gml",
          "heading": false
        }
      ],
      "extract": "Source: Grivell RM, Alfirevic Z, Gyte GML, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database Syst Rev. 2015;(9):CD007863. There was no direct evidence on effects for this intervention. Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "extractCut": false
    },
    {
      "id": "sec-040-eb-table-b24a-early-ultrasound-scan-24-weeks-of",
      "number": null,
      "title": "EB Table B.2.4a: Early ultrasound scan (< 24 weeks of gestation) versus selective/concealed ultrasound scan in early pregnancy)",
      "level": 3,
      "pageStart": 72,
      "pageEnd": 73,
      "labelStart": "64",
      "labelEnd": "65",
      "words": 378,
      "summary": {
        "text": "Evidence base table (EB Table B.2.4a) from Whitworth, Bricker, and Mullan (2015) comparing routine/revealed early ultrasound scan (< 24 weeks of gestation) with selective or concealed early ultrasound. Presents GRADE evidence showing reductions in labour induction for post-term pregnancy (8 RCTs, 25 516 women; RR 0.59, 95% CI 0.42–0.83; low certainty) and maternal dissatisfaction/worry (1 RCT, 634 women; RR 0.80; low certainty), marked increases in detection of major fetal anomalies before birth (2 RCTs, 387 women; RR 3.19; low certainty) and before 24 weeks (RR 3.46; low certainty), and little or no difference in caesarean section (RR 1.05, moderate certainty), small for gestational age (RR 1.05, moderate certainty), perinatal death (10 RCTs, 35 735 births; RR 0.89, low certainty), or low birth weight (RR 0.83, low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ultrasound",
          "heading": true
        },
        {
          "term": "scan",
          "heading": true
        },
        {
          "term": "pregnancy",
          "heading": true
        }
      ],
      "extract": "EB Table B.2.4a: Early ultrasound scan (< 24 weeks of gestation) versus selective/concealed ultrasound scan in early pregnancy) Source: Whitworth M, Bricker L, Mullan C. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev. 2015;(7):CD007058. Outcome No. of participants (studies) Anticipated absolute effects* Relative effect (95% CI) Certainty Risk with selective/concealed ultrasound in",
      "extractCut": true
    },
    {
      "id": "sec-041-eb-table-b24b-late-ultrasound-scan-24-weeks-of-g",
      "number": null,
      "title": "EB Table B.2.4b: Late ultrasound scan (> 24 weeks of gestation) versus no, concealed or selective late ultrasound scan",
      "level": 3,
      "pageStart": 73,
      "pageEnd": 75,
      "labelStart": "65",
      "labelEnd": "67",
      "words": 538,
      "summary": {
        "text": "Evidence base tables (EB Table B.2.4b and EB Table B.2.5a) evaluating late pregnancy ultrasound (> 24 weeks; Bricker, Medley, and Pratt, 2015) and routine fetal/umbilical Doppler ultrasound in normal pregnancy (Alfirevic, Stampalija, and Medley, 2015). EB Table B.2.4b shows no clear difference between routine and no/concealed/selective late ultrasound across caesarean section (RR 1.03, moderate certainty), induction of labour (RR 0.93, moderate certainty), instrumental delivery (RR 1.05, moderate certainty), perinatal mortality (8 RCTs, 30 675 births; RR 1.01, moderate certainty), preterm birth (RR 0.96, moderate certainty), small for gestational age (RR 0.98, low certainty), or low birth weight. EB Table B.2.5a similarly shows no clear difference with all routine Doppler ultrasound versus no Doppler ultrasound in normal pregnancy for caesarean section (RR 0.98, moderate certainty), operative vaginal birth (RR 1.04, moderate certainty), perinatal death (4 RCTs, 11 183 births; RR 0.80, low certainty), or preterm birth (RR 1.02, moderate certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ultrasound",
          "heading": true
        },
        {
          "term": "doppler ultrasound",
          "heading": false
        },
        {
          "term": "routine ultrasound",
          "heading": false
        },
        {
          "term": "fewer",
          "heading": false
        },
        {
          "term": "rcts",
          "heading": false
        },
        {
          "term": "preterm birth",
          "heading": false
        },
        {
          "term": "normal pregnancy",
          "heading": false
        },
        {
          "term": "birth weight",
          "heading": false
        }
      ],
      "extract": "Source: Bricker L, Medley N, Pratt JJ. Routine ultrasound in late pregnancy (after 24 weeks of gestation). Cochrane Database Syst Rev. 2015;(6):CD001451. Outcome No. of participants (studies) Anticipated absolute effects* Relative effect (95% CI) Certainty Risk with no/concealed/ selective ultrasound Risk difference with routine ultrasound Caesarean section 22 663 (6 RCTs) 139 per 1000 4 more per 1000 (11 fewer to",
      "extractCut": true
    },
    {
      "id": "sec-042-eb-table-b25b-multiple-doppler-ultrasound-versus",
      "number": null,
      "title": "EB Table B.2.5b: Multiple Doppler ultrasound versus no Doppler ultrasound in normal pregnancy",
      "level": 3,
      "pageStart": 75,
      "pageEnd": 76,
      "labelStart": "67",
      "labelEnd": "68",
      "words": 193,
      "summary": {
        "text": "Evidence base table (EB Table B.2.5b) from Alfirevic, Stampalija, and Medley (2015) comparing multiple Doppler ultrasound examinations versus no Doppler ultrasound in normal pregnancy. Reports GRADE evidence showing little or no difference in caesarean section for fetal/umbilical vessels plus uterine artery Doppler (1 RCT, 2475 women; RR 0.98, 95% CI 0.74–1.29; 1 fewer per 1000; moderate certainty), perinatal death (3 RCTs, 7292 births; RR 1.04, 95% CI 0.40–2.66; 0 fewer per 1000; low certainty), or preterm birth before 37 weeks (3 RCTs, 8264 women; RR 0.97, 95% CI 0.82–1.15; 2 fewer per 1000; moderate certainty), with operative vaginal birth data not available.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "doppler ultrasound",
          "heading": true
        },
        {
          "term": "pregnancy",
          "heading": true
        },
        {
          "term": "fewer",
          "heading": false
        },
        {
          "term": "multiple",
          "heading": true
        }
      ],
      "extract": "EB Table B.2.5b: Multiple Doppler ultrasound versus no Doppler ultrasound in normal pregnancy Outcome No. of participants (studies) Anticipated absolute effects Relative effect (95% CI) Certainty Risk with no Doppler ultrasound Risk difference with multiple Doppler ultrasound Caesarean section* 2475 (1 RCT) 75 per 1000 1 fewer per 1000 (19 fewer to 22 more) RR 0.98 (0.74 to 1.29) MODERATE 1 Operative vaginal birth",
      "extractCut": true
    },
    {
      "id": "sec-043-eb-table-b25c-single-doppler-ultrasound-versus-n",
      "number": null,
      "title": "EB Table B.2.5c: Single Doppler ultrasound versus no Doppler ultrasound in normal pregnancy",
      "level": 3,
      "pageStart": 76,
      "pageEnd": 77,
      "labelStart": "68",
      "labelEnd": "69",
      "words": 202,
      "summary": {
        "text": "Evidence base table (EB Table B.2.5c) from Alfirevic, Stampalija, and Medley (2015) comparing a single Doppler ultrasound examination versus no Doppler ultrasound in normal pregnancy (1 RCT, 3891 women). Reports GRADE evidence indicating lower perinatal death with single Doppler ultrasound (RR 0.36, 95% CI 0.13–0.99; 5 fewer per 1000 from a 7 per 1000 baseline; low certainty), alongside little or no difference in caesarean section (RR 0.99, 95% CI 0.84–1.16; moderate certainty), operative vaginal birth (RR 1.10, 95% CI 0.95–1.26; moderate certainty), and preterm birth before 37 weeks (RR 1.20, 95% CI 0.86–1.69; very low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "doppler ultrasound",
          "heading": true
        },
        {
          "term": "single doppler",
          "heading": true
        },
        {
          "term": "fewer",
          "heading": false
        },
        {
          "term": "pregnancy",
          "heading": true
        }
      ],
      "extract": "EB Table B.2.5c: Single Doppler ultrasound versus no Doppler ultrasound in normal pregnancy Outcome No. of participants (studies) Anticipated absolute effects Relative effect (95% CI) Certainty Risk with no Doppler ultrasound Risk difference with single Doppler ultrasound Caesarean section 3891 (1 RCT) 129 per 1000 1 fewer per 1000 (21 fewer to 21 more) RR 0.99 (0.84 to 1.16) MODERATE 1 Operative vaginal birth 3891",
      "extractCut": true
    },
    {
      "id": "sec-044-c-preventive-measures",
      "number": "C",
      "title": "Preventive measures",
      "level": 2,
      "pageStart": 77,
      "pageEnd": 77,
      "labelStart": "69",
      "labelEnd": "69",
      "words": 3,
      "summary": {
        "text": "Section heading introducing Part C (Preventive measures) of the WHO antenatal care guideline evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "C. Preventive measures",
      "extractCut": false
    },
    {
      "id": "sec-045-c1-antibiotics-for-asymptomatic-bacteriuria-asb",
      "number": "C.1",
      "title": "Antibiotics for asymptomatic bacteriuria (ASB)",
      "level": 2,
      "pageStart": 77,
      "pageEnd": 77,
      "labelStart": "69",
      "labelEnd": "69",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-046-eb-table-c1-antibiotics-for-asb-versus-no-treatm",
      "number": null,
      "title": "EB Table C.1: Antibiotics for ASB versus no treatment",
      "level": 3,
      "pageStart": 77,
      "pageEnd": 79,
      "labelStart": "69",
      "labelEnd": "71",
      "words": 460,
      "summary": {
        "text": "Evidence base table (EB Table C.1) from the Cochrane review by Smaill and Vazquez (2015) comparing antibiotic treatment for asymptomatic bacteriuria (ASB) in pregnancy against no treatment. Presents GRADE evidence showing reductions in maternal pyelonephritis across any antibiotic regimen (11 RCTs, 1932 women; RR 0.23, 95% CI 0.13–0.41; 160 fewer per 1000; very low certainty), single-dose therapy (1 RCT, 173 women; RR 0.44, 95% CI 0.21–0.92; low certainty), short-course 3–7 day therapy (3 RCTs, 483 women; RR 0.31, 95% CI 0.09–1.16; very low certainty), intermediate 3–6 week therapy (2 RCTs, 433 women; RR 0.17, 95% CI 0.08–0.37; very low certainty), and continuous antibiotic therapy (5 RCTs, 843 women; RR 0.16, 95% CI 0.04–0.57; very low certainty), as well as reductions in persistent bacteriuria (4 RCTs, 596 women; RR 0.30, 95% CI 0.18–0.53; 464 fewer per 1000; low certainty), birth weight < 2500 g (6 RCTs, 1437 births; RR 0.64, 95% CI 0.45–0.93; 49 fewer per 1000; low certainty), and preterm birth < 37 weeks (2 RCTs, 242 births; RR 0.27, 95% CI 0.11–0.62; 162 fewer per 1000; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "regimen randomized",
          "heading": false
        },
        {
          "term": "fewer",
          "heading": false
        },
        {
          "term": "pyelonephritis",
          "heading": false
        }
      ],
      "extract": "Source: Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2015;(8):CD000490. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Antibiotic No treatment Relative (95% CI) Absolute Pyelonephritis – any antibiotic regimen 11 randomized trials very serious1 serious2 no",
      "extractCut": true
    },
    {
      "id": "sec-047-c2-antibiotic-prophylaxis-to-prevent-recurrent-u",
      "number": "C.2",
      "title": "Antibiotic prophylaxis to prevent recurrent urinary tract infections (RUTI)",
      "level": 2,
      "pageStart": 79,
      "pageEnd": 79,
      "labelStart": "71",
      "labelEnd": "71",
      "words": 10,
      "summary": {
        "text": "Subsection heading introducing Section C.2 (Antibiotic prophylaxis to prevent recurrent urinary tract infections [RUTI]) in Part C of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "C.2. Antibiotic prophylaxis to prevent recurrent urinary tract infections (RUTI)",
      "extractCut": false
    },
    {
      "id": "sec-048-eb-table-c2-antibiotic-prophylaxis-to-prevent-re",
      "number": null,
      "title": "EB Table C.2: Antibiotic prophylaxis to prevent recurrent urinary tract infections (RUTI) versus control",
      "level": 3,
      "pageStart": 79,
      "pageEnd": 80,
      "labelStart": "71",
      "labelEnd": "72",
      "words": 311,
      "summary": {
        "text": "Evidence base table (EB Table C.2) from the Cochrane review by Schneeberger et al. (2015) comparing daily nitrofurantoin prophylaxis plus close clinic surveillance against close surveillance alone for preventing recurrent urinary tract infections (RUTI) during pregnancy (1 RCT). Reports GRADE evidence showing reduced asymptomatic bacteriuria among women with >= 90% clinic attendance (102 women; RR 0.55, 95% CI 0.34–0.89; 267 fewer per 1000; low certainty) and very low-certainty, imprecise estimates for recurrent pyelonephritis (167 women; RR 0.89, 95% CI 0.31–2.53), urinary tract infection/cystitis (167 women; RR 0.30, 95% CI 0.06–1.38), preterm birth < 37 weeks (147 women; RR 1.18, 95% CI 0.42–3.35), and low birth weight < 2500 g (147 women; RR 2.03, 95% CI 0.53–7.80).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "urinary tract",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "recurrent",
          "heading": true
        },
        {
          "term": "tract infection",
          "heading": false
        }
      ],
      "extract": "Source: Schneeberger C, Geerlings SE, Middleton P, Crowther CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev. 2015;(7):CD009279. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Nitrofurantoin and close surveillance Control (close surveillance alone) Relative",
      "extractCut": true
    },
    {
      "id": "sec-049-c3-antenatal-anti-d-immunoglobulin-prophylaxis",
      "number": "C.3",
      "title": "Antenatal anti-D immunoglobulin prophylaxis",
      "level": 2,
      "pageStart": 80,
      "pageEnd": 80,
      "labelStart": "72",
      "labelEnd": "72",
      "words": 5,
      "summary": {
        "text": "Subsection heading introducing Section C.3 (Antenatal anti-D immunoglobulin prophylaxis) in Part C of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "C.3. Antenatal anti-D immunoglobulin prophylaxis",
      "extractCut": false
    },
    {
      "id": "sec-050-eb-table-c3-antenatal-anti-d-immunoglobulin-prop",
      "number": null,
      "title": "EB Table C.3: Antenatal anti-D immunoglobulin prophylaxis versus control",
      "level": 3,
      "pageStart": 80,
      "pageEnd": 82,
      "labelStart": "72",
      "labelEnd": "74",
      "words": 805,
      "summary": {
        "text": "Evidence base table (EB Table C.3) from the Cochrane review by McBain, Crowther, and Middleton (2015) comparing routine antenatal anti-D immunoglobulin prophylaxis in Rhesus-negative pregnant women against no routine antenatal anti-D administration. Presents GRADE evidence showing reduced positive Kleihauer fetomaternal haemorrhage tests at 32–35 weeks of gestation (1 RCT, 1884 women; RR 0.60, 95% CI 0.41–0.88; 28 fewer per 1000; low certainty) and at birth of an Rh-positive infant (1 RCT, 1189 women; RR 0.60, 95% CI 0.46–0.79; 81 fewer per 1000; low certainty), alongside very low-certainty estimates across overall, 100-microgram, and 50-microgram regimens (at 28 and 34 weeks) for Rhesus D alloimmunization during pregnancy (any regimen: 2 RCTs, 3902 women; RR 0.42, 95% CI 0.15–1.17), postpartum at birth of an Rh-positive infant (any regimen: 2 RCTs, 2297 women; RR 0.42, 95% CI 0.15–1.17), postpartum through 12 months of follow-up (any regimen: 2 RCTs, 2048 women; RR 0.39, 95% CI 0.10–1.62; primigravidae at 2–12 months: 1 RCT, 722 women; RR 0.11, 95% CI 0.01–2.04), and neonatal jaundice (1 RCT, 1882 neonates; RR 0.26, 95% CI 0.03–2.30).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "antenatal anti-d",
          "heading": true
        },
        {
          "term": "rhesus alloimmunization",
          "heading": false
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "alloimmunization postpartum",
          "heading": false
        },
        {
          "term": "rh-positive infant",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "pregnancy micrograms",
          "heading": false
        }
      ],
      "extract": "Source: McBain RD, Crowther CA, Middleton P. Anti-D administration in pregnancy for preventing Rhesus alloimmunization. Cochrane Database Syst Rev. 2015;(9):CD000020. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Anti-D administration in pregnancy Control (no routine antenatal anti-D administration) Relative (95% CI)",
      "extractCut": true
    },
    {
      "id": "sec-051-c4-preventive-anthelminthic-treatment",
      "number": "C.4",
      "title": "Preventive anthelminthic treatment",
      "level": 2,
      "pageStart": 82,
      "pageEnd": 82,
      "labelStart": "74",
      "labelEnd": "74",
      "words": 4,
      "summary": {
        "text": "Subsection heading introducing Section C.4 (Preventive anthelminthic treatment) in Part C of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "C.4. Preventive anthelminthic treatment",
      "extractCut": false
    },
    {
      "id": "sec-052-eb-table-c4-preventive-anthelminthic-treatment-v",
      "number": null,
      "title": "EB Table C.4: Preventive anthelminthic treatment versus control",
      "level": 3,
      "pageStart": 82,
      "pageEnd": 83,
      "labelStart": "74",
      "labelEnd": "75",
      "words": 250,
      "summary": {
        "text": "Evidence base table (EB Table C.4) from the Cochrane review by Salam et al. (2015) evaluating preventive anthelminthic administration for soil-transmitted helminths during pregnancy versus no routine anthelminthics. Reports GRADE evidence showing little or no difference in third-trimester maternal anaemia (< 110 g/L; 4 RCTs, 3266 women; RR 0.94, 95% CI 0.81–1.10; 20 fewer per 1000; low certainty), low birth weight (3 RCTs, 3255 births; RR 1.00, 95% CI 0.79–1.27; moderate certainty), preterm birth (2 RCTs, 1318 births; RR 0.88, 95% CI 0.43–1.78; very low certainty), or perinatal mortality (2 RCTs, 3385 births; RR 1.09, 95% CI 0.71–1.67; moderate certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "fewer",
          "heading": false
        }
      ],
      "extract": "Source: Salam RA, Haider BA, Humayun Q, Bhutta ZA. Effect of administration of anthelminthics for soil-transmitted helminths during pregnancy. Cochrane Database Syst Rev. 2015;(6):CD005547. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Antihelminthics Control (no routine anthelminthics) Relative (95% CI) Absolute",
      "extractCut": true
    },
    {
      "id": "sec-053-c5-tetanus-toxoid-vaccination",
      "number": "C.5",
      "title": "Tetanus toxoid vaccination",
      "level": 2,
      "pageStart": 83,
      "pageEnd": 83,
      "labelStart": "75",
      "labelEnd": "75",
      "words": 4,
      "summary": {
        "text": "Subsection heading introducing Section C.5 (Tetanus toxoid vaccination) in Part C of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "C.5. Tetanus toxoid vaccination",
      "extractCut": false
    },
    {
      "id": "sec-054-eb-table-c5-tetanus-toxoid-tt-vaccination-versus",
      "number": null,
      "title": "EB Table C.5: Tetanus toxoid (TT) vaccination versus influenza vaccination",
      "level": 3,
      "pageStart": 83,
      "pageEnd": 84,
      "labelStart": "75",
      "labelEnd": "76",
      "words": 299,
      "summary": {
        "text": "Evidence base table (EB Table C.5) from the Cochrane review by Demicheli, Barale, and Rivetti (2015) comparing maternal tetanus toxoid (TT) vaccination with influenza vaccination control for preventing neonatal tetanus (1 RCT). Summarizes GRADE evidence demonstrating substantial reductions in neonatal tetanus cases with any TT dose (1182 infants; RR 0.20, 95% CI 0.10–0.40; 64 fewer per 1000; low certainty), neonatal tetanus deaths after two or three doses (688 infants; RR 0.02, 95% CI 0.00–0.30; 76 fewer per 1000; low certainty), and all-cause neonatal deaths after two or three doses (688 infants; RR 0.31, 95% CI 0.17–0.55; 91 fewer per 1000; moderate certainty), while single-dose estimates for neonatal tetanus deaths (494 infants; RR 0.57, 95% CI 0.26–1.24; very low certainty) and all-cause deaths (494 infants; RR 1.08, 95% CI 0.65–1.79; low certainty) were imprecise.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "tetanus",
          "heading": true
        },
        {
          "term": "neonatal tetanus",
          "heading": false
        },
        {
          "term": "tetanus deaths",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        }
      ],
      "extract": "Source: Demicheli V, Barale A, Rivetti A. Vaccines for women for preventing neonatal tetanus. Cochrane Database Syst Rev. 2015;(7):CD002959. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations TT vaccine Influenza vaccine Relative (95% CI) Absolute Neonatal tetanus cases – any dose 1 randomized trials serious1 serious2 no",
      "extractCut": true
    },
    {
      "id": "sec-055-d-interventions-for-common-physiological-symptom",
      "number": "D",
      "title": "Interventions for common physiological symptoms",
      "level": 2,
      "pageStart": 84,
      "pageEnd": 84,
      "labelStart": "76",
      "labelEnd": "76",
      "words": 6,
      "summary": {
        "text": "Section heading introducing Part D (Interventions for common physiological symptoms) of the WHO antenatal care guideline evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "D. Interventions for common physiological symptoms",
      "extractCut": false
    },
    {
      "id": "sec-056-d1-nausea-and-vomiting",
      "number": "D.1",
      "title": "Nausea and vomiting",
      "level": 2,
      "pageStart": 84,
      "pageEnd": 84,
      "labelStart": "76",
      "labelEnd": "76",
      "words": 22,
      "summary": {
        "text": "Subsection heading and source citation for Section D.1 (Nausea and vomiting), citing the Cochrane review by Matthews et al. (2015) on interventions for nausea and vomiting in early pregnancy.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Source: Matthews A, Haas DM, O’Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015;(9):CD007575.",
      "extractCut": false
    },
    {
      "id": "sec-057-eb-table-d1a-p6-acupressure-versus-placebo",
      "number": null,
      "title": "EB Table D.1a: P6 acupressure versus placebo",
      "level": 3,
      "pageStart": 84,
      "pageEnd": 85,
      "labelStart": "76",
      "labelEnd": "77",
      "words": 467,
      "summary": {
        "text": "Evidence base table (EB Table D.1a) from Matthews et al. (2015) comparing P6 (Neiguan) acupressure with placebo for nausea and vomiting in early pregnancy. Reports GRADE evidence from single-trial comparisons showing lower nausea severity on a 10 cm visual analogue scale (VAS) after 4 days of treatment (100 women; MD 1.70 lower, 95% CI 2.41–0.99 lower; low certainty) and fewer vomiting episodes after 4 days (100 women; MD 0.90 lower, 95% CI 1.06–0.74 lower; low certainty), alongside uncertain or non-significant effects on failure to improve symptom intensity (97 women; RR 0.78, 95% CI 0.44–1.39; low certainty), mean VAS nausea after day 3 (40 women; MD 0.10 higher; low certainty) or averaged over days 1–3 (60 women; MD 0.39 higher; very low certainty), mean Rhodes Index total scores on days 1–3 (60 women; MD 1.17 higher; very low certainty) or day 3 (93 women; MD 1.48 lower; very low certainty), and mean emesis scores on days 1–3 (60 women; MD 0.26 higher; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "acupressure",
          "heading": true
        },
        {
          "term": "lower values",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations P6 acupressure Control (placebo) Relative (95% CI) Absolute Severity of nausea after treatment (of 4 days) using a 10 cm visual analogue scale (VAS; better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness very serious2",
      "extractCut": true
    },
    {
      "id": "sec-058-eb-table-d1b-auricular-acupressure-versus-placeb",
      "number": null,
      "title": "EB Table D.1b: Auricular acupressure versus placebo",
      "level": 3,
      "pageStart": 85,
      "pageEnd": 86,
      "labelStart": "77",
      "labelEnd": "78",
      "words": 96,
      "summary": {
        "text": "Evidence base table (EB Table D.1b) from Matthews et al. (2015) comparing auricular acupressure against placebo for nausea and vomiting in early pregnancy (1 RCT, 91 women). Reports low-certainty GRADE evidence (downgraded for baseline score imbalance, lack of blinding, and small sample size) of a lower combined Rhodes Index nausea/vomiting score on day 6 (3 days after starting treatment; MD 3.60 lower, 95% CI 6.62–0.58 lower).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "auricular",
          "heading": true
        },
        {
          "term": "acupressure",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Auricular acupressure Control (placebo) Relative (95% CI) Absolute Nausea/vomiting score (combined Rhodes Index score) on day 6 (3 days after treatment started) (MD; better indicated by lower values) 1 randomized trials very serious1 no serious inconsistency no serious",
      "extractCut": true
    },
    {
      "id": "sec-059-eb-table-d1c-acustimulation-therapy-at-p6-point",
      "number": null,
      "title": "EB Table D.1c: Acustimulation therapy at P6 point versus placebo",
      "level": 3,
      "pageStart": 86,
      "pageEnd": 86,
      "labelStart": "78",
      "labelEnd": "78",
      "words": 130,
      "summary": {
        "text": "Evidence base table (EB Table D.1c) from Matthews et al. (2015) comparing acustimulation therapy at the P6 point against placebo in early pregnancy (1 RCT, 187 women). Presents low-certainty GRADE evidence (downgraded for outcome indirectness and imprecision) showing greater maternal weight gain over a 3-week period (MD 1.70 lbs higher, 95% CI 0.23–3.17 higher) and fewer reported occurrences of dehydration (RR 0.24, 95% CI 0.07–0.83; 99 fewer per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "acustimulation therapy",
          "heading": true
        },
        {
          "term": "inconsistency serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        }
      ],
      "extract": "EB Table D.1c: Acustimulation therapy at P6 point versus placebo Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Acustimulation therapy at P6 point Control (placebo) Relative (95% CI) Absolute Weight gain (in lbs) over 3 week period (MD; better indicated by lower values) 1 randomized trials no serious risk of bias no",
      "extractCut": true
    },
    {
      "id": "sec-060-eb-table-d1d-traditional-acupuncture-versus-plac",
      "number": null,
      "title": "EB Table D.1d: Traditional acupuncture versus placebo",
      "level": 3,
      "pageStart": 86,
      "pageEnd": 87,
      "labelStart": "78",
      "labelEnd": "79",
      "words": 102,
      "summary": {
        "text": "Evidence base table (EB Table D.1d) from Matthews et al. (2015) comparing traditional acupuncture against placebo for nausea and vomiting in early pregnancy (1 RCT, 296 women). Reports low-certainty GRADE evidence of a slightly lower mean nausea score on day 7 (MD 0.70 lower, 95% CI 1.36–0.04 lower).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "acupuncture",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Traditional acupuncture Control (placebo) Relative (95% CI) Absolute Mean nausea score on day 7 (MD; better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 148 148 MD 0.7 lower (1.36 to 0.04 lower) - LOW",
      "extractCut": true
    },
    {
      "id": "sec-061-eb-table-d1e-p6-acupuncture-versus-placebo",
      "number": null,
      "title": "EB Table D.1e: P6 acupuncture versus placebo",
      "level": 3,
      "pageStart": 87,
      "pageEnd": 88,
      "labelStart": "79",
      "labelEnd": "80",
      "words": 192,
      "summary": {
        "text": "Evidence base table (EB Table D.1e) from Matthews et al. (2015) comparing P6 acupuncture against placebo for nausea and vomiting in early pregnancy (1 RCT, 296 women). Reports low-certainty GRADE evidence showing no clear difference on day 7 in mean nausea score (MD 0.30 lower, 95% CI 1.00 lower to 0.40 higher), mean dry retching score (MD 0.10 higher, 95% CI 0.30 lower to 0.50 higher), or mean vomiting score (MD 0.30 lower, 95% CI 0.78 lower to 0.18 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "acupuncture",
          "heading": true
        },
        {
          "term": "lower values",
          "heading": false
        }
      ],
      "extract": "EB Table D.1e: P6 acupuncture versus placebo Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations P6 acupuncture Control (placebo) Relative (95% CI) Absolute Mean nausea score on day 7 (MD; better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 148 148 MD",
      "extractCut": true
    },
    {
      "id": "sec-062-eb-table-d1f-ginger-versus-placebo",
      "number": null,
      "title": "EB Table D.1f: Ginger versus placebo",
      "level": 3,
      "pageStart": 88,
      "pageEnd": 89,
      "labelStart": "80",
      "labelEnd": "81",
      "words": 361,
      "summary": {
        "text": "Evidence base table (EB Table D.1f) from Matthews et al. (2015) comparing ginger with placebo for nausea and vomiting in early pregnancy. Summarizes GRADE evidence from single-trial comparisons showing improvements with ginger across mean Rhodes Index nausea score on day 3 (68 women; MD 1.38 lower, 95% CI 2.73–0.03 lower; low certainty), mean Rhodes Index vomiting score on day 3 (68 women; MD 1.14 lower, 95% CI 1.91–0.37 lower; low certainty), total Rhodes Index score on day 3 (68 women; MD 2.52 lower, 95% CI 4.50–0.54 lower; low certainty) and after 1 week of treatment (70 women; MD 4.19 lower, 95% CI 6.65–1.73 lower; low certainty), fewer women with little improvement in nausea (23 women; RR 0.29, 95% CI 0.10–0.82; 568 fewer per 1000; moderate certainty), and fewer women continuing to vomit at day 6 (22 women; RR 0.42, 95% CI 0.18–0.98; 464 fewer per 1000; moderate certainty), alongside a low-certainty estimate for overall symptom improvement (62 women; RR 1.25, 95% CI 0.96–1.63).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "ginger",
          "heading": true
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "rhodes index",
          "heading": false
        }
      ],
      "extract": "EB Table D.1f: Ginger versus placebo Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Ginger Control (placebo) Relative (95% CI) Absolute Mean nausea score (using Rhodes Index) on day 3 (MD; better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 34 34",
      "extractCut": true
    },
    {
      "id": "sec-063-eb-table-d1g-lemon-oil-versus-placebo",
      "number": null,
      "title": "EB Table D.1g: Lemon oil versus placebo",
      "level": 3,
      "pageStart": 89,
      "pageEnd": 89,
      "labelStart": "81",
      "labelEnd": "81",
      "words": 186,
      "summary": {
        "text": "Evidence base table (EB Table D.1g) from Matthews et al. (2015) comparing lemon oil inhalation against placebo for nausea and vomiting in early pregnancy (1 RCT, 100 women). Reports low-certainty GRADE evidence showing a lower total Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score from baseline to day 3 (MD 1.50 lower, 95% CI 2.41–0.59 lower), but imprecise differences in mean PUQE score on day 3 alone (MD 0.46 lower, 95% CI 1.27 lower to 0.35 higher) and maternal satisfaction with treatment (RR 1.47, 95% CI 0.91–2.37).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lemon oil",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        },
        {
          "term": "puqe",
          "heading": false
        }
      ],
      "extract": "EB Table D.1g: Lemon oil versus placebo Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Lemon oil Control (placebo) Relative (95% CI) Absolute Mean nausea and vomiting (PUQE) score on day 3 of intervention (better indicated by lower values) 1 randomized trials no serious risk of bias no serious inconsistency no serious",
      "extractCut": true
    },
    {
      "id": "sec-064-eb-table-d1h-mint-oil-versus-placebo",
      "number": null,
      "title": "EB Table D.1h: Mint oil versus placebo",
      "level": 3,
      "pageStart": 89,
      "pageEnd": 90,
      "labelStart": "81",
      "labelEnd": "82",
      "words": 149,
      "summary": {
        "text": "Evidence base table (EB Table D.1h) from Matthews et al. (2015) comparing mint oil against placebo for nausea and vomiting in early pregnancy (1 RCT, 60 women). Reports very low-certainty GRADE evidence showing no clear difference on day 4 in nausea severity (MD 0.88 lower, 95% CI 1.93 lower to 0.17 higher) or vomiting intensity (MD 0.32 lower, 95% CI 1.45 lower to 0.81 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "mint",
          "heading": true
        },
        {
          "term": "lower values",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Mint oil Control (placebo) Relative (95% CI) Absolute Severity of nausea on day 4 (MD; better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2,3 none 30 30 MD 0.88 lower (1.93 lower to 0.17 higher) - VERY LOW",
      "extractCut": true
    },
    {
      "id": "sec-065-eb-table-d1i-chamomile-versus-placebo",
      "number": null,
      "title": "EB Table D.1i: Chamomile versus placebo",
      "level": 3,
      "pageStart": 90,
      "pageEnd": 90,
      "labelStart": "82",
      "labelEnd": "82",
      "words": 91,
      "summary": {
        "text": "Evidence base table (EB Table D.1i) from Matthews et al. (2015) comparing chamomile against placebo for nausea and vomiting in early pregnancy (1 RCT, 70 women). Reports low-certainty GRADE evidence of a lower Rhodes Index score after 1 week of treatment with chamomile (MD 5.74 lower, 95% CI 8.31–3.17 lower).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "chamomile",
          "heading": true
        },
        {
          "term": "placebo",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        }
      ],
      "extract": "EB Table D.1i: Chamomile versus placebo Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Chamomile Control (placebo) Relative (95% CI) Absolute Rhodes Index score after 1 week treatment (Better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness no serious imprecision",
      "extractCut": true
    },
    {
      "id": "sec-066-eb-table-d1j-vitamin-b6-versus-placebo",
      "number": null,
      "title": "EB Table D.1j: Vitamin B6 versus placebo",
      "level": 3,
      "pageStart": 90,
      "pageEnd": 91,
      "labelStart": "82",
      "labelEnd": "83",
      "words": 142,
      "summary": {
        "text": "Evidence base table (EB Table D.1j) from Matthews et al. (2015) comparing oral vitamin B6 (pyridoxine) against placebo for nausea and vomiting in early pregnancy (2 RCTs). Reports GRADE evidence showing a greater mean reduction in nausea score after 3 days of vitamin B6 therapy (393 women; MD 0.92 higher reduction, 95% CI 0.40–1.44 higher; moderate certainty), but no clear reduction in the number of women with post-therapy emesis (392 women; RR 0.76, 95% CI 0.35–1.66; 88 fewer per 1000; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        },
        {
          "term": "vitamin",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Vitamin B6 Control (placebo) Relative (95% CI) Absolute Mean reduction in nausea score after 3 days (better indicated by lower values) 2 randomized trials no serious risk of bias no serious inconsistency no serious indirectness no serious imprecision none1 199 194 MD 0.92",
      "extractCut": true
    },
    {
      "id": "sec-067-eb-table-d1k-p6-acupressure-versus-vitamin-b6",
      "number": null,
      "title": "EB Table D.1k: P6 acupressure versus vitamin B6",
      "level": 3,
      "pageStart": 91,
      "pageEnd": 91,
      "labelStart": "83",
      "labelEnd": "83",
      "words": 129,
      "summary": {
        "text": "Evidence base table (EB Table D.1k) from Matthews et al. (2015) comparing P6 acupressure directly against vitamin B6 for nausea and vomiting in early pregnancy (1 RCT). Reports GRADE evidence showing no clear difference in day-3 nausea scores (66 women; MD 0.20 higher, 95% CI 2.24 lower to 2.64 higher; low certainty), but fewer tablets of rescue medication required for poor symptom relief with P6 acupressure (60 women; MD 2.20 lower, 95% CI 3.98–0.42 lower; moderate certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "acupressure",
          "heading": true
        },
        {
          "term": "serious risk",
          "heading": false
        }
      ],
      "extract": "EB Table D.1k: P6 acupressure versus vitamin B6 Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations P6 acupressure Control (vitamin B6) Relative (95% CI) Absolute Nausea scores on day 3 (better indicated by lower values) 1 randomized trials no serious risk of bias no serious inconsistency no serious indirectness very",
      "extractCut": true
    },
    {
      "id": "sec-068-eb-table-d1l-traditional-acupuncture-versus-p6-a",
      "number": null,
      "title": "EB Table D.1l: Traditional acupuncture versus P6 acupuncture",
      "level": 3,
      "pageStart": 91,
      "pageEnd": 92,
      "labelStart": "83",
      "labelEnd": "84",
      "words": 176,
      "summary": {
        "text": "Evidence base table (EB Table D.1l) from Matthews et al. (2015) comparing traditional acupuncture directly against P6 acupuncture for nausea and vomiting in early pregnancy (1 RCT, 296 women). Reports low-certainty GRADE evidence showing no clear difference on day 7 in mean nausea score (MD 0.40 lower, 95% CI 1.12 lower to 0.32 higher), mean dry retching score (MD 0.30 lower, 95% CI 0.65 lower to 0.05 higher), or mean vomiting score (MD 0.20 higher, 95% CI 0.26 lower to 0.66 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "acupuncture",
          "heading": true
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "lower values",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Traditional acupuncture Control (P6 acupuncture) Relative (95% CI) Absolute Mean nausea score on day 7 (better indicated by lower values) 1 randomized trials no serious risk of bias no serious inconsistency no serious indirectness very serious1,2 none 148 148 MD 0.4 lower",
      "extractCut": true
    },
    {
      "id": "sec-069-eb-table-d1m-ginger-versus-p6-acupressure",
      "number": null,
      "title": "EB Table D.1m: Ginger versus P6 acupressure",
      "level": 3,
      "pageStart": 92,
      "pageEnd": 92,
      "labelStart": "84",
      "labelEnd": "84",
      "words": 92,
      "summary": {
        "text": "Evidence base table (EB Table D.1m) from Matthews et al. (2015) comparing ginger against P6 acupressure for nausea and vomiting in early pregnancy (1 RCT, 98 women). Reports low-certainty GRADE evidence of no clear difference in total Rhodes Index score on the 3rd day of intervention (MD 2.27 higher with ginger, 95% CI 0.01 lower to 4.55 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "versus acupressure",
          "heading": true
        },
        {
          "term": "ginger versus",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        }
      ],
      "extract": "EB Table D.1m: Ginger versus P6 acupressure Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Ginger versus P6 acupressure Control Relative (95% CI) Absolute Total Rhodes Index score on the 3rd day of intervention (better indicated by lower values) 1 randomized trials no serious risk of bias no serious inconsistency no",
      "extractCut": true
    },
    {
      "id": "sec-070-eb-table-d1n-ginger-versus-chamomile",
      "number": null,
      "title": "EB Table D.1n: Ginger versus chamomile",
      "level": 3,
      "pageStart": 92,
      "pageEnd": 93,
      "labelStart": "84",
      "labelEnd": "85",
      "words": 106,
      "summary": {
        "text": "Evidence base table (EB Table D.1n) from Matthews et al. (2015) comparing ginger against chamomile for nausea and vomiting in early pregnancy (1 RCT, 70 women). Reports low-certainty GRADE evidence showing no clear difference in Rhodes Index score after 1 week of treatment (MD 1.55 higher with ginger, 95% CI 0.34 lower to 3.44 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "chamomile",
          "heading": true
        },
        {
          "term": "ginger",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Ginger Chamomile Relative (95% CI) Absolute Rhodes Index score after 1 week treatment (better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 35 35 MD 1.55 higher (0.34 lower to 3.44 higher) - LOW 1. Most",
      "extractCut": true
    },
    {
      "id": "sec-071-eb-table-d1o-ginger-versus-vitamin-b6",
      "number": null,
      "title": "EB Table D.1o: Ginger versus vitamin B6",
      "level": 3,
      "pageStart": 93,
      "pageEnd": 94,
      "labelStart": "85",
      "labelEnd": "86",
      "words": 294,
      "summary": {
        "text": "Evidence base table (EB Table D.1o) from Matthews et al. (2015) comparing ginger directly against vitamin B6 for nausea and vomiting in early pregnancy. Summarizes low-certainty GRADE evidence showing little or no difference between ginger and vitamin B6 in pooled day-3 nausea and vomiting scores (2 RCTs, 251 women; SMD 0.00, 95% CI -0.25 to 0.25), day-3 Rhodes Index score (1 RCT, 123 women; SMD 0.09 lower, 95% CI -0.44 to 0.27), day-3 10 cm VAS score (1 RCT, 128 women; SMD 0.08 higher, 95% CI -0.27 to 0.43), day-3 post-treatment vomiting episodes (1 RCT, 128 women; MD 0.00, 95% CI -0.60 to 0.60), or lack of symptom improvement (2 RCTs, 360 women; RR 0.84, 95% CI 0.47–1.52).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "nausea vomiting",
          "heading": false
        },
        {
          "term": "ginger",
          "heading": true
        },
        {
          "term": "vomiting score",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "lower values",
          "heading": false
        }
      ],
      "extract": "EB Table D.1o: Ginger versus vitamin B6 Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Ginger Vitamin B6 Relative (95% CI) Absolute Nausea vomiting score day 3 (better indicated by lower values) 2 randomized trials no serious risk of bias no serious inconsistency no serious indirectness very serious1,2 none 125 126 SMD 0",
      "extractCut": true
    },
    {
      "id": "sec-072-eb-table-d1p-vitamin-b6-high-dose-versus-vitamin",
      "number": null,
      "title": "EB Table D.1p: Vitamin B6 (high dose) versus vitamin B6 (low dose)",
      "level": 3,
      "pageStart": 94,
      "pageEnd": 94,
      "labelStart": "86",
      "labelEnd": "86",
      "words": 88,
      "summary": {
        "text": "Evidence base table (EB Table D.1p) from Matthews et al. (2015) comparing high-dose versus low-dose vitamin B6 for nausea and vomiting in early pregnancy (1 RCT, 60 women). Reports low-certainty GRADE evidence of a slightly greater reduction in PUQE score from baseline to 2 weeks with high-dose vitamin B6 (MD 1.06 lower, 95% CI 2.05–0.07 lower).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vitamin",
          "heading": true
        },
        {
          "term": "dose",
          "heading": true
        },
        {
          "term": "puqe",
          "heading": false
        }
      ],
      "extract": "EB Table D.1p: Vitamin B6 (high dose) versus vitamin B6 (low dose) Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Vitamin B6 (high dose) Vitamin B6 (low dose) Relative (95% CI) Absolute Mean change in PUQE score from baseline to 2 weeks (better indicated by lower values) 1 randomized trials serious no serious",
      "extractCut": true
    },
    {
      "id": "sec-073-eb-table-d1q-ginger-versus-metoclopramide",
      "number": null,
      "title": "EB Table D.1q: Ginger versus metoclopramide",
      "level": 3,
      "pageStart": 94,
      "pageEnd": 95,
      "labelStart": "86",
      "labelEnd": "87",
      "words": 183,
      "summary": {
        "text": "Evidence base table (EB Table D.1q) from Matthews et al. (2015) comparing ginger against metoclopramide for nausea and vomiting in early pregnancy (1 RCT, 68 women). Reports low-certainty GRADE evidence showing no clear difference on day 3 in mean Rhodes Index nausea score (MD 1.56 higher with ginger, 95% CI 0.22 lower to 3.34 higher), mean vomiting score (MD 0.33 higher, 95% CI 0.69 lower to 1.35 higher), or total Rhodes Index score (MD 1.89 higher, 95% CI 0.78 lower to 4.56 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "rhodes index",
          "heading": false
        },
        {
          "term": "lower values",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Ginger Metoclopramide Relative (95% CI) Absolute Mean score for nausea (using Rhodes Index) on day 3 (better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 34 34 MD 1.56 higher (0.22 lower to 3.34",
      "extractCut": true
    },
    {
      "id": "sec-074-eb-table-d1r-doxylamine-and-pyridoxine-versus-pl",
      "number": null,
      "title": "EB Table D.1r: Doxylamine and pyridoxine versus placebo",
      "level": 3,
      "pageStart": 95,
      "pageEnd": 95,
      "labelStart": "87",
      "labelEnd": "87",
      "words": 173,
      "summary": {
        "text": "Evidence base table (EB Table D.1r) from Matthews et al. (2015) comparing combined doxylamine and pyridoxine (vitamin B6) against placebo for nausea and vomiting in early pregnancy (1 RCT, 256 women). Reports GRADE evidence showing a greater improvement in nausea, vomiting, and retching on the PUQE scale from baseline to day 15 (MD 0.90 lower, 95% CI 1.55–0.25 lower; moderate certainty), with no clear difference in maternal headache (RR 0.81, 95% CI 0.45–1.48; low certainty) or somnolence (RR 1.21, 95% CI 0.64–2.27; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "doxylamine",
          "heading": true
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "pyridoxine",
          "heading": true
        }
      ],
      "extract": "EB Table D.1r: Doxylamine and pyridoxine versus placebo Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Doxylamine and pyridoxine Control (placebo) Relative (95% CI) Absolute Mean difference in nausea/vomiting/retching (PUQE score) baseline to day 15 (better indicated by lower values) 1 randomized trials no serious risk",
      "extractCut": true
    },
    {
      "id": "sec-075-eb-table-d1s-metoclopramide-versus-placebo",
      "number": null,
      "title": "EB Table D.1s: Metoclopramide versus placebo",
      "level": 3,
      "pageStart": 95,
      "pageEnd": 96,
      "labelStart": "87",
      "labelEnd": "88",
      "words": 102,
      "summary": {
        "text": "Evidence base table (EB Table D.1s) from Matthews et al. (2015) comparing metoclopramide against placebo for nausea and vomiting in early pregnancy (1 RCT, 68 women). Reports moderate-certainty GRADE evidence of a lower mean Rhodes Index nausea score on day 3 with metoclopramide (MD 2.94 lower, 95% CI 4.55–1.33 lower).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "metoclopramide",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Metoclopramide Control (placebo) Relative (95% CI) Absolute Mean score for nausea (using Rhodes Index) on day 3 (better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness no serious imprecision none 34 34 MD 2.94 lower",
      "extractCut": true
    },
    {
      "id": "sec-076-eb-table-d1t-ondansetron-versus-metoclopramide",
      "number": null,
      "title": "EB Table D.1t: Ondansetron versus metoclopramide",
      "level": 3,
      "pageStart": 96,
      "pageEnd": 96,
      "labelStart": "88",
      "labelEnd": "88",
      "words": 144,
      "summary": {
        "text": "Evidence base table (EB Table D.1t) from Matthews et al. (2015) comparing ondansetron against metoclopramide for nausea and vomiting in early pregnancy (1 RCT, 70 women). Reports very low-certainty GRADE evidence showing no clear difference on day 3 after treatment in average nausea episodes (MD 0.12 lower, 95% CI 0.44 lower to 0.20 higher) or average vomiting episodes (MD 0.20 lower, 95% CI 0.57 lower to 0.17 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ondansetron",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "metoclopramide",
          "heading": true
        },
        {
          "term": "serious none",
          "heading": false
        }
      ],
      "extract": "EB Table D.1t: Ondansetron versus metoclopramide Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Ondansetron Metoclopramide Relative (95% CI) Absolute Average number of nausea episodes on day 3 after treatment (better indicated by lower values) 1 randomized trials very serious1 no serious inconsistency no serious",
      "extractCut": true
    },
    {
      "id": "sec-077-eb-table-d1u-ondansetron-versus-pyridoxine-doxyl",
      "number": null,
      "title": "EB Table D.1u: Ondansetron versus pyridoxine-doxylamine",
      "level": 3,
      "pageStart": 96,
      "pageEnd": 97,
      "labelStart": "88",
      "labelEnd": "89",
      "words": 195,
      "summary": {
        "text": "Evidence base table (EB Table D.1u) from Matthews et al. (2015) comparing ondansetron against combined pyridoxine–doxylamine for nausea and vomiting in early pregnancy (1 RCT, 30 women). Reports low-certainty GRADE evidence of a higher rate of clinically significant (>= 25 mm VAS) nausea reduction after 5 days with ondansetron (RR 2.24, 95% CI 1.24–4.04; 511 more per 1000) and imprecise differences in sedation (RR 0.75, 95% CI 0.28–2.02) and constipation (RR 2.18, 95% CI 0.63–7.50).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "ondansetron",
          "heading": true
        },
        {
          "term": "randomized trials",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Ondansetron Pyridoxine- doxylamine Relative (95% CI) Absolute Clinically significant ( 25 mm on VAS) reduction in nausea after 5 days of treatment 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 12/13 (92.3%) 7/17 (41.2%) RR 2.24",
      "extractCut": true
    },
    {
      "id": "sec-078-d2-interventions-for-heartburn",
      "number": "D.2",
      "title": "Interventions for heartburn",
      "level": 2,
      "pageStart": 97,
      "pageEnd": 97,
      "labelStart": "89",
      "labelEnd": "89",
      "words": 19,
      "summary": {
        "text": "Subsection heading and source citation for Section D.2 (Interventions for heartburn), citing the Cochrane review by Phupong and Hanprasertpong (2015) on interventions for heartburn in pregnancy.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "D.2. Interventions for heartburn Source: Phupong V, Hanprasertpong T. Interventions for heartburn in pregnancy. Cochrane Database Syst Rev. 2015;(9):CD011379.",
      "extractCut": false
    },
    {
      "id": "sec-079-eb-table-d2a-any-pharmacological-treatment-versu",
      "number": null,
      "title": "EB Table D.2a: Any pharmacological treatment versus placebo or no treatment",
      "level": 3,
      "pageStart": 97,
      "pageEnd": 98,
      "labelStart": "89",
      "labelEnd": "90",
      "words": 195,
      "summary": {
        "text": "Evidence base table (EB Table D.2a) from the Cochrane review by Phupong and Hanprasertpong (2015) comparing any pharmacological treatment for heartburn in pregnancy against placebo or no treatment (2 RCTs, 256 women). Reports GRADE evidence showing increased complete relief of heartburn with pharmacological therapy (RR 1.85, 95% CI 1.36–2.50; 256 more per 1000; moderate certainty), with very low-certainty, imprecise estimates for partial heartburn relief (RR 1.35, 95% CI 0.38–4.76) and maternal side-effects (RR 0.63, 95% CI 0.21–1.89).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "heartburn randomized",
          "heading": false
        },
        {
          "term": "pharmacological",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Any pharmacological treatment Control (placebo or no treatment) Relative (95% CI) Absolute Complete relief of heartburn 2 randomized trials serious1 no serious inconsistency no serious indirectness no serious imprecision none 75/133 (56.4%) 37/123 (30.1%) RR 1.85 (1.36 to",
      "extractCut": true
    },
    {
      "id": "sec-080-eb-table-d2b-pharmacological-treatment-versus-li",
      "number": null,
      "title": "EB Table D.2b: Pharmacological treatment versus lifestyle change",
      "level": 3,
      "pageStart": 98,
      "pageEnd": 98,
      "labelStart": "90",
      "labelEnd": "90",
      "words": 135,
      "summary": {
        "text": "Evidence base table (EB Table D.2b) from Phupong and Hanprasertpong (2015) comparing pharmacological treatment against lifestyle modification for heartburn in pregnancy (1 RCT). Reports GRADE evidence showing higher complete relief of heartburn with pharmacological treatment (65 women; RR 2.41, 95% CI 1.42–4.07; 529 more per 1000; low certainty) and very low-certainty evidence on side-effects (66 women; RR 1.74, 95% CI 0.07–41.21).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lifestyle change",
          "heading": true
        },
        {
          "term": "pharmacological treatment",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        }
      ],
      "extract": "EB Table D.2b: Pharmacological treatment versus lifestyle change Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Pharmacological treatment Lifestyle change Relative (95% CI) Absolute Complete relief of heartburn 1 randomized trials serious1 no serious inconsistency no serious indirectness serious none 37/41 (90.2%) 9/24",
      "extractCut": true
    },
    {
      "id": "sec-081-eb-table-d2c-acupuncture-versus-no-treatment",
      "number": null,
      "title": "EB Table D.2c: Acupuncture versus no treatment",
      "level": 3,
      "pageStart": 98,
      "pageEnd": 99,
      "labelStart": "90",
      "labelEnd": "91",
      "words": 112,
      "summary": {
        "text": "Evidence base table (EB Table D.2c) from Phupong and Hanprasertpong (2015) comparing acupuncture against no treatment for heartburn in pregnancy (1 RCT, 36 women). Reports low-certainty GRADE evidence of improved quality of life measured as ability to sleep with acupuncture (RR 2.80, 95% CI 1.14–6.86; 450 more per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "acupuncture",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        },
        {
          "term": "indirectness",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Acupuncture Control (no treatment) Relative (95% CI) Absolute Quality of life – improvement in the ability to sleep 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 14/20 (70%) 4/16 (25%) RR 2.8 (1.14 to 6.86) 450 more per 1000",
      "extractCut": true
    },
    {
      "id": "sec-082-d3-interventions-for-leg-cramps",
      "number": "D.3",
      "title": "Interventions for leg cramps",
      "level": 2,
      "pageStart": 99,
      "pageEnd": 99,
      "labelStart": "91",
      "labelEnd": "91",
      "words": 27,
      "summary": {
        "text": "Subsection heading and source citation for Section D.3 (Interventions for leg cramps), citing the Cochrane review by Zhou et al. (2015) on interventions for leg cramps in pregnancy.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "D.3. Interventions for leg cramps Source: Zhou K, West HM, Zhang J, Xu L, Li W. Interventions for leg cramps in pregnancy. Cochrane Database Syst Rev. 2015;(8):CD010655.",
      "extractCut": false
    },
    {
      "id": "sec-083-eb-table-d3a-oral-magnesium-versus-placebo-or-no",
      "number": null,
      "title": "EB Table D.3a: Oral magnesium versus placebo or no treatment",
      "level": 3,
      "pageStart": 99,
      "pageEnd": 101,
      "labelStart": "91",
      "labelEnd": "93",
      "words": 445,
      "summary": {
        "text": "Evidence base table (EB Table D.3a) from the Cochrane review by Zhou et al. (2015) comparing oral magnesium supplementation against placebo or no treatment for leg cramps in pregnancy. Summarizes GRADE evidence from single-trial analyses showing a higher proportion of women achieving a >= 50% reduction in the number of leg cramps (86 women; RR 1.42, 95% CI 1.09–1.86; 254 more per 1000; high certainty) and no leg cramps after treatment in one trial (69 women; RR 5.66, 95% CI 1.35–23.68; 266 more per 1000; low certainty), alongside uncertain effects in a second trial on partial improvement (42 women; RR 1.07, 95% CI 0.71–1.61; very low certainty) or complete recovery (42 women; RR 3.00, 95% CI 0.68–13.20; very low certainty) and imprecise low-certainty estimates for nausea (86 women; RR 1.83, 95% CI 0.75–4.51), diarrhoea (86 women; RR 6.00, 95% CI 0.75–47.76), and any gastrointestinal side-effects (45 women; RR 0.96, 95% CI 0.36–2.52).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "oral magnesium",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "leg cramps",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Oral magnesium Placebo/no treatment Relative (95% CI) Absolute No leg cramps after treatment 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 11/34 (32.4%) 2/35 (5.7%) RR 5.66 (1.35 to 23.68) 266 more per 1000 (from 20 more to 1000",
      "extractCut": true
    },
    {
      "id": "sec-084-eb-table-d3b-oral-calcium-versus-no-treatment",
      "number": null,
      "title": "EB Table D.3b: Oral calcium versus no treatment",
      "level": 3,
      "pageStart": 101,
      "pageEnd": 102,
      "labelStart": "93",
      "labelEnd": "94",
      "words": 224,
      "summary": {
        "text": "Evidence base table (EB Table D.3b) from the Cochrane review by Zhou et al. (2015) comparing oral calcium supplementation against no treatment for leg cramps in pregnancy (1 RCT). Reports GRADE evidence showing higher rates of no leg cramps after treatment (43 women; RR 8.59, 95% CI 1.19–62.07; 361 more per 1000; low certainty) and complete recovery on a composite intensity/frequency outcome (42 women; RR 5.50, 95% CI 1.38–21.86; 429 more per 1000; low certainty), alongside a very low-certainty, imprecise estimate for partial symptom improvement (42 women; RR 0.64, 95% CI 0.36–1.15; 240 fewer per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "oral calcium",
          "heading": true
        },
        {
          "term": "leg cramps",
          "heading": false
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        }
      ],
      "extract": "EB Table D.3b: Oral calcium versus no treatment Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Oral calcium No treatment Relative (95% CI) Absolute No leg cramps after treatment 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 9/22 (40.9%) 1/21 (4.8%) RR 8.59 (1.19 to 62.07) 361",
      "extractCut": true
    },
    {
      "id": "sec-085-eb-table-d3c-vitamin-b1-and-b6-versus-no-treatme",
      "number": null,
      "title": "EB Table D.3c: Vitamin B1 and B6 versus no treatment",
      "level": 3,
      "pageStart": 102,
      "pageEnd": 102,
      "labelStart": "94",
      "labelEnd": "94",
      "words": 147,
      "summary": {
        "text": "Evidence base table (EB Table D.3c) from Zhou et al. (2015) comparing combined oral vitamin B1 and B6 supplementation against no treatment for leg cramps in pregnancy (1 RCT, 42 women). Reports low-certainty GRADE evidence (downgraded for risk of bias, small sample size, and few events) showing a higher rate of complete recovery with no leg cramps after treatment (RR 7.50, 95% CI 1.95–28.81; 619 more per 1000) and correspondingly fewer women experiencing only partial improvement in cramp intensity and frequency (RR 0.29, 95% CI 0.11–0.73; 473 fewer per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        }
      ],
      "extract": "EB Table D.3c: Vitamin B1 and B6 versus no treatment Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Oral vitamin B1 and B6 No treatment Relative (95% CI) Absolute Partial improvement: decrease in intensity and frequency 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 4/21 (19%)",
      "extractCut": true
    },
    {
      "id": "sec-086-eb-table-d3d-oral-calcium-versus-oral-vitamin-c",
      "number": null,
      "title": "EB Table D.3d: Oral calcium versus oral vitamin C",
      "level": 3,
      "pageStart": 102,
      "pageEnd": 103,
      "labelStart": "94",
      "labelEnd": "95",
      "words": 117,
      "summary": {
        "text": "Evidence base table (EB Table D.3d) from Zhou et al. (2015) comparing oral calcium against oral vitamin C for leg cramps in pregnancy (1 RCT, 60 women). Reports low-certainty GRADE evidence (downgraded for risk of bias, small sample size, few events, and a wide confidence interval) showing no clear difference in the proportion of women with no leg cramps after treatment (RR 1.33, 95% CI 0.53–3.38; 66 more per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "oral",
          "heading": true
        },
        {
          "term": "calcium",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Oral calcium Oral vitamin C Relative (95% CI) Absolute No leg cramps after treatment 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2,3 none 8/30 (26.7%) 6/30 (20%) RR 1.33 (0.53 to 3.38) 66 more per 1000 (from 94 fewer to 476 more) LOW",
      "extractCut": true
    },
    {
      "id": "sec-087-d4-interventions-for-low-back-and-pelvic-pain",
      "number": "D.4",
      "title": "Interventions for low back and pelvic pain",
      "level": 2,
      "pageStart": 103,
      "pageEnd": 103,
      "labelStart": "95",
      "labelEnd": "95",
      "words": 29,
      "summary": {
        "text": "Subsection heading and source citation for Section D.4 (Interventions for low back and pelvic pain), citing the Cochrane review by Liddle and Pennick (2015) on interventions for preventing and treating low-back and pelvic pain during pregnancy.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pelvic pain",
          "heading": true
        },
        {
          "term": "back",
          "heading": true
        },
        {
          "term": "liddle",
          "heading": false
        }
      ],
      "extract": "D.4. Interventions for low back and pelvic pain Source: Liddle SD, Pennick V. Interventions for preventing and treating low-back and pelvic pain during pregnancy. Cochrane Database Syst Rev. 2015;(9):CD001139.",
      "extractCut": false
    },
    {
      "id": "sec-088-eb-table-d4a-any-exercise-plus-usual-antenatal-c",
      "number": null,
      "title": "EB Table D.4a: Any exercise plus usual antenatal care (ANC) versus usual ANC",
      "level": 3,
      "pageStart": 103,
      "pageEnd": 104,
      "labelStart": "95",
      "labelEnd": "96",
      "words": 199,
      "summary": {
        "text": "Evidence base table (EB Table D.4a) from the Cochrane review by Liddle and Pennick (2015) comparing any exercise intervention plus usual antenatal care (ANC) against usual ANC alone for low back and pelvic pain during pregnancy. Summarizes GRADE evidence showing reductions in low back pain intensity (7 RCTs, 645 women; SMD 0.64 lower, 95% CI 1.03–0.25 lower; very low certainty), functional disability (2 RCTs, 146 women; SMD 0.56 lower, 95% CI 0.89–0.23 lower; low certainty), and the proportion of women reporting pain on a visual analogue scale (4 RCTs, 1176 women; RR 0.66, 95% CI 0.45–0.97; 241 fewer per 1000; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "usual anc",
          "heading": true
        },
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "imprecision none",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Any exercise + usual ANC Usual ANC Relative (95% CI) Absolute Low back pain intensity (better indicated by lower values) 7 randomized trials very serious1 serious2 no serious indirectness no serious imprecision none 321 324 SMD 0.64 lower (1.03 to 0.25 lower) - VERY LOW",
      "extractCut": true
    },
    {
      "id": "sec-089-eb-table-d4b-bellybra-versus-tubigrip-support-be",
      "number": null,
      "title": "EB Table D.4b: Bellybra versus Tubigrip support belts",
      "level": 3,
      "pageStart": 104,
      "pageEnd": 104,
      "labelStart": "96",
      "labelEnd": "96",
      "words": 141,
      "summary": {
        "text": "Evidence base table (EB Table D.4b) from Liddle and Pennick (2015) comparing Bellybra versus Tubigrip maternity support belts for low back pain in pregnancy (1 RCT, 94 women). Reports very low-certainty GRADE evidence (downgraded for risk of bias, small sample size, and wide confidence intervals) showing no clear difference in visual analogue scale (VAS) low-back pain (MD 0.20 lower, 95% CI 1.19 lower to 0.79 higher) or functional disability (MD 0.90 lower, 95% CI 1.81 lower to 0.01 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "bellybra",
          "heading": true
        },
        {
          "term": "tubigrip",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        }
      ],
      "extract": "EB Table D.4b: Bellybra versus Tubigrip support belts Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Bellybra Tubigrip Relative (95% CI) Absolute Low-back pain – measured with visual analogue scale (VAS) (MD; better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness",
      "extractCut": true
    },
    {
      "id": "sec-090-eb-table-d4c-acupuncture-plus-usual-anc-versus-u",
      "number": null,
      "title": "EB Table D.4c: Acupuncture plus usual ANC versus usual ANC",
      "level": 3,
      "pageStart": 104,
      "pageEnd": 105,
      "labelStart": "96",
      "labelEnd": "97",
      "words": 93,
      "summary": {
        "text": "Evidence base table (EB Table D.4c) from Liddle and Pennick (2015) comparing acupuncture plus usual antenatal care (ANC) against usual ANC alone for low back and pelvic pain in pregnancy (1 RCT, 72 women). Reports low-certainty GRADE evidence showing a higher proportion of women with decreased low back and pelvic pain in the acupuncture group (RR 4.16, 95% CI 1.77–9.78; 451 more per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "usual anc",
          "heading": true
        },
        {
          "term": "acupuncture",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Acupuncture + usual ANC Usual ANC Relative (95% CI) Absolute Decreased low back and pelvic pain 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 22/37 (59.5%) 5/35 (14.3%) RR 4.16 (1.77 to 9.78) 451 more per 1000 (from 110 more to",
      "extractCut": true
    },
    {
      "id": "sec-091-eb-table-d4d-acupuncture-plus-usual-anc-versus-i",
      "number": null,
      "title": "EB Table D.4d: Acupuncture plus usual ANC versus individualized physiotherapy plus usual ANC",
      "level": 3,
      "pageStart": 105,
      "pageEnd": 105,
      "labelStart": "97",
      "labelEnd": "97",
      "words": 116,
      "summary": {
        "text": "Evidence base table (EB Table D.4d) from Liddle and Pennick (2015) comparing acupuncture plus usual antenatal care (ANC) against individualized physiotherapy plus usual ANC for low back and pelvic pain in pregnancy (1 RCT, 46 women). Reports very low-certainty GRADE evidence showing an imprecise difference in the proportion of women rating their treatment as good or excellent (RR 1.24, 95% CI 0.96–1.60; 187 more per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "usual anc",
          "heading": true
        },
        {
          "term": "individualized physiotherapy",
          "heading": true
        },
        {
          "term": "plus usual",
          "heading": true
        },
        {
          "term": "acupuncture",
          "heading": true
        }
      ],
      "extract": "EB Table D.4d: Acupuncture plus usual ANC versus individualized physiotherapy plus usual ANC Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Acupuncture + usual ANC Individualized physiotherapy + usual ANC Relative (95% CI) Absolute Women rating treatment as good or excellent 1 randomized trials very serious1 no serious",
      "extractCut": true
    },
    {
      "id": "sec-092-eb-table-d4e-multimodal-intervention-manual-ther",
      "number": null,
      "title": "EB Table D.4e: Multimodal intervention (manual therapy/chiropractic, exercise at home and education) versus usual care (rest, exercise, heat pads and analgesics)",
      "level": 3,
      "pageStart": 105,
      "pageEnd": 106,
      "labelStart": "97",
      "labelEnd": "98",
      "words": 122,
      "summary": {
        "text": "Evidence base table (EB Table D.4e) from Liddle and Pennick (2015) comparing a multimodal intervention (manual therapy/chiropractic care, home exercise, and education) against usual care (rest, exercise, heat pads, and analgesics) for low back and pelvic pain in pregnancy (1 RCT, 169 women; source table column headers mislabelled as Bellybra/Tubigrip). Reports moderate-certainty GRADE evidence (downgraded for small sample size) of lower pain scores (MD 2.70 lower, 95% CI 3.54–1.86 lower) and lower functional disability scores (MD 1.40 lower, 95% CI 2.09–0.71 lower) with the multimodal intervention.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "imprecision serious",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        }
      ],
      "extract": "(rest, exercise, heat pads and analgesics) Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Bellybra Tubigrip Relative (95% CI) Absolute Pain (MD; better indicated by lower values) 1 randomized trials no serious risk of bias no serious inconsistency no serious indirectness no serious imprecision serious1 87 82 MD 2.7 lower",
      "extractCut": true
    },
    {
      "id": "sec-093-d5-interventions-for-constipation",
      "number": "D.5",
      "title": "Interventions for constipation",
      "level": 2,
      "pageStart": 106,
      "pageEnd": 106,
      "labelStart": "98",
      "labelEnd": "98",
      "words": 26,
      "summary": {
        "text": "Subsection heading and source citation for Section D.5 (Interventions for constipation), citing the Cochrane review by Rungsiprakarn et al. (2015) on interventions for treating constipation in pregnancy.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "D.5. Interventions for constipation Source: Rungsiprakarn P, Laopaiboon M, Sangkomkamhang US, Lumbiganon P, Pratt JJ. Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev. 2015;(9):CD011448.",
      "extractCut": false
    },
    {
      "id": "sec-094-eb-table-d5a-fibre-supplementation-versus-no-int",
      "number": null,
      "title": "EB Table D.5a: Fibre supplementation versus no intervention",
      "level": 3,
      "pageStart": 106,
      "pageEnd": 107,
      "labelStart": "98",
      "labelEnd": "99",
      "words": 109,
      "summary": {
        "text": "Evidence base table (EB Table D.5a) from the Cochrane review by Rungsiprakarn et al. (2015) comparing dietary fibre supplementation against no intervention for constipation in pregnancy (1 RCT, 40 women; source table column headers mislabelled as Any exercise + usual ANC / Usual ANC). Reports very low-certainty GRADE evidence of increased weekly stool frequency with fibre supplementation (MD 2.24 higher per week, 95% CI 0.96–3.52 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "usual anc",
          "heading": false
        },
        {
          "term": "serious",
          "heading": false
        },
        {
          "term": "indirectness",
          "heading": false
        },
        {
          "term": "inconsistency",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Any exercise + usual ANC Usual ANC Relative (95% CI) Absolute Frequency of stools (per week) (better indicated by higher values) 1 randomized trials very serious1 no serious inconsistency no serious indirectness serious2 none 27 13 MD 2.24 higher (0.96 to 3.52 higher) - VERY",
      "extractCut": true
    },
    {
      "id": "sec-095-eb-table-d5b-stimulant-laxatives-versus-bulk-for",
      "number": null,
      "title": "EB Table D.5b: Stimulant laxatives versus bulk-forming laxatives",
      "level": 3,
      "pageStart": 107,
      "pageEnd": 108,
      "labelStart": "99",
      "labelEnd": "100",
      "words": 232,
      "summary": {
        "text": "Evidence base table (EB Table D.5b) from Rungsiprakarn et al. (2015) comparing stimulant laxatives against bulk-forming laxatives for constipation in pregnancy (1 RCT, 140 women). Reports GRADE evidence showing greater improvement in constipation (RR 1.59, 95% CI 1.21–2.09; 287 more per 1000; low certainty) but higher rates of abdominal discomfort (RR 2.33, 95% CI 1.15–4.73; 171 more per 1000; low certainty) and diarrhoea (RR 4.50, 95% CI 1.01–20.09; 100 more per 1000; very low certainty) with stimulant laxatives, and no clear difference in women's satisfaction (RR 1.06, 95% CI 0.77–1.46; very low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "bulk-forming laxatives",
          "heading": true
        },
        {
          "term": "stimulant laxatives",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        }
      ],
      "extract": "EB Table D.5b: Stimulant laxatives versus bulk-forming laxatives Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Stimulant laxatives Bulk-forming laxatives Relative (95% CI) Absolute Improvement in constipation 1 randomized trials very serious1 no serious inconsistency no serious indirectness no serious imprecision none",
      "extractCut": true
    },
    {
      "id": "sec-096-d6-interventions-for-varicose-veins-and-oedema",
      "number": "D.6",
      "title": "Interventions for varicose veins and oedema",
      "level": 2,
      "pageStart": 108,
      "pageEnd": 108,
      "labelStart": "100",
      "labelEnd": "100",
      "words": 28,
      "summary": {
        "text": "Subsection heading and source citation for Section D.6 (Interventions for varicose veins and oedema), citing the Cochrane review by Smyth, Aflaifel, and Bamigboye (2015) on interventions for varicose veins and leg oedema in pregnancy.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "D.6. Interventions for varicose veins and oedema Source: Smyth RMD, Aflaifel N, Bamigboye AA. Interventions for varicose veins and leg oedema in pregnancy. Cochrane Database Syst Rev. 2015;(10):CD001066.",
      "extractCut": false
    },
    {
      "id": "sec-097-eb-table-d6a-rutoside-versus-placebo",
      "number": null,
      "title": "EB Table D.6a: Rutoside versus placebo",
      "level": 3,
      "pageStart": 108,
      "pageEnd": 109,
      "labelStart": "100",
      "labelEnd": "101",
      "words": 192,
      "summary": {
        "text": "Evidence base table (EB Table D.6a) from the Cochrane review by Smyth, Aflaifel, and Bamigboye (2015) comparing oral rutoside against placebo for varicose veins in pregnancy (1 RCT, 69 women). Reports GRADE evidence showing greater relief of varicose-vein symptoms with rutoside (RR 1.89, 95% CI 1.11–3.22; 306 more per 1000; low certainty), alongside very low-certainty, imprecise estimates for maternal side-effects (RR 1.30, 95% CI 0.23–7.28; 19 more per 1000) and deep vein thrombosis complications (RR 0.17, 95% CI 0.01–3.49; 52 fewer per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "varicose veins",
          "heading": false
        },
        {
          "term": "rutoside",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Rutoside Placebo Relative (95% CI) Absolute Relief of symptoms associated with varicose veins 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 24/37 (64.9%) 11/32 (34.4%) RR 1.89 (1.11 to 3.22) 306 more per 1000 (from 38 more to 763",
      "extractCut": true
    },
    {
      "id": "sec-098-eb-table-d6b-external-pneumatic-intermittent-com",
      "number": null,
      "title": "EB Table D.6b: External pneumatic intermittent compression versus rest",
      "level": 3,
      "pageStart": 109,
      "pageEnd": 109,
      "labelStart": "101",
      "labelEnd": "101",
      "words": 94,
      "summary": {
        "text": "Evidence base table (EB Table D.6b) from Smyth, Aflaifel, and Bamigboye (2015) comparing external pneumatic intermittent compression against rest for leg oedema in pregnancy (1 RCT, 35 women). Reports low-certainty GRADE evidence (downgraded for a wide confidence interval crossing no effect) on change in lower leg volume (MD 258.8 lower, 95% CI 566.91 lower to 49.31 higher; unit of analysis not stated).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pneumatic intermittent",
          "heading": true
        },
        {
          "term": "intermittent compression",
          "heading": true
        },
        {
          "term": "external pneumatic",
          "heading": true
        }
      ],
      "extract": "EB Table D.6b: External pneumatic intermittent compression versus rest Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations External pneumatic intermittent compression Rest Relative (95% CI) Absolute Symptoms associated with oedema (change in lower leg volume, unit of analysis not stated) (MD; better indicated by lower values)",
      "extractCut": true
    },
    {
      "id": "sec-099-eb-table-d6c-reflexology-versus-rest",
      "number": null,
      "title": "EB Table D.6c: Reflexology versus rest",
      "level": 3,
      "pageStart": 109,
      "pageEnd": 110,
      "labelStart": "101",
      "labelEnd": "102",
      "words": 148,
      "summary": {
        "text": "Evidence base table (EB Table D.6c) from Smyth, Aflaifel, and Bamigboye (2015) comparing foot reflexology against rest for leg oedema in pregnancy (1 RCT). Reports GRADE evidence showing reduced symptoms associated with oedema (43 women; RR 9.09, 95% CI 1.41–58.54; 809 more per 1000; low certainty) and a very low-certainty, imprecise estimate for women's satisfaction (55 women; RR 6.00, 95% CI 0.92–39.11; 500 more per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "reflexology",
          "heading": true
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Reflexology Rest Relative (95% CI) Absolute Woman's satisfaction 1 randomized trials serious1 no serious inconsistency no serious indirectness very serious2,3 none 27/45 (60%) 1/10 (10%) RR 6 (0.92 to 39.11) 500 more per 1000 (from 8 fewer to 1000 more) VERY LOW Symptoms",
      "extractCut": true
    },
    {
      "id": "sec-100-eb-table-d6d-water-immersion-versus-leg-elevatio",
      "number": null,
      "title": "EB Table D.6d: Water immersion versus leg elevation",
      "level": 3,
      "pageStart": 110,
      "pageEnd": 110,
      "labelStart": "102",
      "labelEnd": "102",
      "words": 102,
      "summary": {
        "text": "Evidence base table (EB Table D.6d) from Smyth, Aflaifel, and Bamigboye (2015) comparing water immersion against leg elevation for leg oedema in pregnancy (1 RCT, 32 women). Reports low-certainty GRADE evidence (downgraded for risk of bias, small sample size, and few events) showing a smaller proportion of women with reduced leg volume in the water-immersion group as tabulated (6/16 vs 14/16; RR 0.43, 95% CI 0.22–0.83; 499 fewer per 1000).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "leg elevation",
          "heading": true
        },
        {
          "term": "water immersion",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        }
      ],
      "extract": "EB Table D.6d: Water immersion versus leg elevation Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Water immersion Leg elevation Relative (95% CI) Absolute Women with reduction in leg volume (oedema) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 6/16 (37.5%) 14/16 (87.5%) RR",
      "extractCut": true
    },
    {
      "id": "sec-101-eb-table-d6e-foot-massage-versus-routine-care",
      "number": null,
      "title": "EB Table D.6e: Foot massage versus “routine care”",
      "level": 3,
      "pageStart": 110,
      "pageEnd": 111,
      "labelStart": "102",
      "labelEnd": "103",
      "words": 109,
      "summary": {
        "text": "Evidence base table (EB Table D.6e) from Smyth, Aflaifel, and Bamigboye (2015) comparing foot massage against routine care for leg oedema in pregnancy (1 RCT, 80 women). Reports low-certainty GRADE evidence showing no clear difference in lower leg circumference in centimetres (MD 0.11 cm lower, 95% CI 1.02 lower to 0.80 higher).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "massage",
          "heading": true
        },
        {
          "term": "foot",
          "heading": true
        },
        {
          "term": "serious",
          "heading": false
        },
        {
          "term": "lower",
          "heading": false
        }
      ],
      "extract": "Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Foot massage Routine care Relative (95% CI) Absolute Symptoms associated with oedema (lower leg circumference in centimetres; better indicated by lower values) 1 randomized trials serious1 no serious inconsistency no serious indirectness serious2 none 40 40 MD 0.11 lower",
      "extractCut": true
    },
    {
      "id": "sec-102-e-health-systems-interventions-to-improve-antena",
      "number": "E",
      "title": "Health systems interventions to improve antenatal care utilization and quality",
      "level": 2,
      "pageStart": 111,
      "pageEnd": 111,
      "labelStart": "103",
      "labelEnd": "103",
      "words": 11,
      "summary": {
        "text": "Section heading introducing Part E (Health systems interventions to improve antenatal care utilization and quality) of the WHO antenatal care guideline evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "E. Health systems interventions to improve antenatal care utilization and quality",
      "extractCut": false
    },
    {
      "id": "sec-103-e1-woman-held-case-notes",
      "number": "E.1",
      "title": "Woman-held case notes",
      "level": 2,
      "pageStart": 111,
      "pageEnd": 111,
      "labelStart": "103",
      "labelEnd": "103",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-104-eb-table-e1-woman-held-case-notes-versus-control",
      "number": null,
      "title": "EB Table E.1: Woman-held case notes versus control",
      "level": 3,
      "pageStart": 111,
      "pageEnd": 112,
      "labelStart": "103",
      "labelEnd": "104",
      "words": 278,
      "summary": {
        "text": "Evidence base table (EB Table E.1) from the Cochrane review by Brown et al. (2015) comparing woman-held case notes during pregnancy against facility-held control notes. Summarizes GRADE evidence showing that women carrying their own case notes were more likely to feel in control of their care (2 RCTs, 450 women; RR 1.56, 95% CI 1.18–2.06; 132 more per 1000; moderate certainty), with no clear difference in overall satisfaction with antenatal care (2 RCTs, 698 women; RR 1.02, 95% CI 0.92–1.29; low certainty), notes lost or left at home (2 RCTs, 347 women; RR 0.38, 95% CI 0.04–3.84; very low certainty), or stillbirth and neonatal death (2 RCTs, 713 women; RR 0.77, 95% CI 0.17–3.48; low certainty), alongside a very low-certainty estimate of increased caesarean section in one cluster-randomized trial (501 women; RR 1.51, 95% CI 1.10–2.08).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "case notes",
          "heading": true
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        },
        {
          "term": "own case",
          "heading": false
        },
        {
          "term": "unexplained",
          "heading": false
        }
      ],
      "extract": "Source: Brown HC, Smith HJ, Mori R, Noma H. Giving women their own case notes to carry during pregnancy. Cochrane Database Syst Rev. 2015;(10):CD002856. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Women carrying their own case notes Control (facility-held case notes) Relative (95% CI) Absolute Women who felt in",
      "extractCut": true
    },
    {
      "id": "sec-105-e2-midwife-led-continuity-of-care-mlcc",
      "number": "E.2",
      "title": "Midwife-led continuity of care (MLCC)",
      "level": 2,
      "pageStart": 112,
      "pageEnd": 112,
      "labelStart": "104",
      "labelEnd": "104",
      "words": 6,
      "summary": {
        "text": "Subsection heading introducing Section E.2 (Midwife-led continuity of care [MLCC]) in Part E of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "E.2. Midwife-led continuity of care (MLCC)",
      "extractCut": false
    },
    {
      "id": "sec-106-eb-table-e2-mlcc-versus-other-models",
      "number": null,
      "title": "EB Table E.2: MLCC versus other models",
      "level": 3,
      "pageStart": 112,
      "pageEnd": 113,
      "labelStart": "104",
      "labelEnd": "105",
      "words": 389,
      "summary": {
        "text": "Evidence base table (EB Table E.2) from the Cochrane review by Sandall et al. (2015) comparing midwife-led continuity of care (MLCC) models against other models of care for childbearing women. Presents GRADE evidence showing that MLCC increased spontaneous vaginal birth (12 RCTs, 16 687 women; RR 1.05, 95% CI 1.03–1.07; 33 more per 1000; moderate certainty) and maternal satisfaction with antenatal care (4 RCTs, 5419 women; RR 1.31, 95% CI 1.11–1.54; 157 more per 1000; low certainty), while reducing preterm birth < 37 weeks (8 RCTs, 13 238 women; RR 0.76, 95% CI 0.64–0.91; 15 fewer per 1000; moderate certainty), overall fetal loss and neonatal death (13 RCTs, 17 561 births; RR 0.84, 95% CI 0.71–0.99; 5 fewer per 1000; moderate certainty), instrumental vaginal birth (13 RCTs, 17 501 women; RR 0.90, 95% CI 0.83–0.97; 14 fewer per 1000; low certainty), and possibly caesarean birth (14 RCTs, 17 674 women; RR 0.92, 95% CI 0.84–1.00; 12 fewer per 1000; low certainty), with no clear difference in low birth weight < 2500 g (7 RCTs, 11 458 births; RR 0.96, 95% CI 0.82–1.13; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "serious indirectness",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "vaginal birth",
          "heading": false
        },
        {
          "term": "mlcc",
          "heading": true
        }
      ],
      "extract": "Source: Sandall J, Soltani H, Gates S, Shennan A, Devane D. Midwife-led continuity models versus other models of care for childbearing women. Cochrane Database Syst Rev. 2015;(9):CD004667. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations MLCC Other models Relative (95% CI) Absolute Caesarean birth 14 randomized trials",
      "extractCut": true
    },
    {
      "id": "sec-107-figure-e2-additional-analysis-mlcc-model-versus",
      "number": null,
      "title": "Figure E.2: Additional analysis: MLCC model versus other models of care: satisfaction",
      "level": 3,
      "pageStart": 113,
      "pageEnd": 114,
      "labelStart": "105",
      "labelEnd": "106",
      "words": 26,
      "summary": {
        "text": "Figure caption for Figure E.2 presenting an additional forest-plot analysis comparing maternal satisfaction between midwife-led continuity of care (MLCC) models and other models of care.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Figure E.2: Additional analysis: MLCC model versus other models of care: satisfaction Web supplement: WHO recommendations on antenatal care for a positive pregnancy experience: evidence base",
      "extractCut": false
    },
    {
      "id": "sec-108-e3-group-antenatal-care-anc",
      "number": "E.3",
      "title": "Group antenatal care (ANC)",
      "level": 2,
      "pageStart": 114,
      "pageEnd": 114,
      "labelStart": "106",
      "labelEnd": "106",
      "words": 5,
      "summary": {
        "text": "Subsection heading introducing Section E.3 (Group antenatal care [ANC]) in Part E of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "E.3. Group antenatal care (ANC)",
      "extractCut": false
    },
    {
      "id": "sec-109-eb-table-e3-group-anc-versus-individual-anc",
      "number": null,
      "title": "EB Table E.3: Group ANC versus individual ANC",
      "level": 3,
      "pageStart": 114,
      "pageEnd": 116,
      "labelStart": "106",
      "labelEnd": "108",
      "words": 454,
      "summary": {
        "text": "Evidence base table (EB Table E.3) from the Cochrane review by Catling et al. (2015) comparing group antenatal care (ANC) against conventional individual ANC. Summarizes GRADE evidence showing higher maternal satisfaction with group ANC in one US CenteringPregnancy trial (993 women; MD 4.90 higher, 95% CI 3.10–6.70 higher; low certainty) and a borderline reduction in preterm birth (3 RCTs, 1888 women; RR 0.75, 95% CI 0.57–1.00; 26 fewer per 1000; moderate certainty), with no clear difference in spontaneous vaginal birth (1 RCT, 322 women; RR 0.96, 95% CI 0.80–1.15; moderate certainty), caesarean section (2 RCTs, 842 women; RR 0.83, 95% CI 0.68–1.02; very low certainty), small-for-gestational-age infants (2 RCTs, 1473 births; RR 0.92, 95% CI 0.68–1.24; very low certainty), low birth weight (3 RCTs, 1935 births; RR 0.92, 95% CI 0.68–1.23; moderate certainty), or perinatal mortality (3 RCTs, 1943 births; RR 0.63, 95% CI 0.32–1.25; low certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "group anc",
          "heading": true
        },
        {
          "term": "inconsistency serious",
          "heading": false
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious risk",
          "heading": false
        },
        {
          "term": "randomized trials",
          "heading": false
        }
      ],
      "extract": "Source: Catling CJ, Medley N, Foureur M, Ryan C, Leap N, Teate A, Homer CSE. Group versus conventional antenatal care for women. Cochrane Database Syst Rev. 2015;(2):CD007622. Quality assessment No. of women Effect Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Group ANC Individual antenatal care (adjusted data) Relative (95% CI) Absolute Spontaneous vaginal",
      "extractCut": true
    },
    {
      "id": "sec-110-e4-community-based-interventions-to-improve-comm",
      "number": "E.4",
      "title": "Community-based interventions to improve communication and support",
      "level": 2,
      "pageStart": 116,
      "pageEnd": 116,
      "labelStart": "108",
      "labelEnd": "108",
      "words": 8,
      "summary": {
        "text": "Subsection heading introducing Section E.4 (Community-based interventions to improve communication and support) in Part E of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "E.4. Community-based interventions to improve communication and support",
      "extractCut": false
    },
    {
      "id": "sec-111-eb-table-e4-community-based-interventions-womens",
      "number": null,
      "title": "EB Table E.4: Community-based interventions (women’s groups, home visits or intervention packages with home visits and community mobilization) versus control",
      "level": 3,
      "pageStart": 116,
      "pageEnd": 119,
      "labelStart": "108",
      "labelEnd": "111",
      "words": 802,
      "summary": {
        "text": "Evidence base table (EB Table E.4) from the Cochrane review by Mbuagbaw et al. (2015) comparing community-based interventions (participatory women's groups, home visits, or combined home-visit and community-mobilization packages) against control across cluster-randomized trials. Presents GRADE evidence showing increases in ANC coverage of at least one visit with women's groups (3 RCTs, 66 089 women; RR 1.77, 95% CI 1.21–2.58; moderate certainty) and with combined home visits plus community mobilization (4 RCTs, 143 098 women; RR 1.76, 95% CI 1.43–2.16; high certainty), as well as reduced perinatal mortality with combined packages (3 RCTs, 29 282 births; RR 0.65, 95% CI 0.48–0.88; moderate certainty), alongside non-significant or borderline effects across subgroups on ANC coverage of four or more visits (women's groups: RR 1.05, low certainty; home visits: RR 1.09, high certainty; combined packages: RR 1.51, moderate certainty), health-facility deliveries (women's groups: RR 1.04, low certainty; home visits: RR 1.08, moderate certainty; combined packages: RR 1.46, moderate certainty), maternal mortality (women's groups: 7 RCTs, 116 805 women, RR 0.78, 95% CI 0.60–1.03, low certainty; combined packages: 2 RCTs, RR 0.76, moderate certainty), perinatal mortality with women's groups (6 RCTs, RR 0.91, low certainty) or home visits (4 RCTs, RR 0.91, high certainty), and low birth weight (RR 0.78, moderate certainty) or preterm birth (RR 0.88, moderate certainty) with home visits.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "home visits",
          "heading": true
        },
        {
          "term": "visits women",
          "heading": true
        },
        {
          "term": "community mobilization",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        }
      ],
      "extract": "community mobilization) versus control Source: Mbuagbaw L, Medley N, Darzi AJ, Richardson M, Habiba Garga K, Ongolo-Zogo P. Health system and community level interventions for improving antenatal care coverage and health outcomes. Cochrane Database Syst Rev. 2015;(12):CD010994. Quality assessment No. of women1 Effect2 Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other",
      "extractCut": true
    },
    {
      "id": "sec-112-e7-antenatal-care-contact-schedules",
      "number": "E.7",
      "title": "Antenatal care contact schedules",
      "level": 2,
      "pageStart": 119,
      "pageEnd": 119,
      "labelStart": "111",
      "labelEnd": "111",
      "words": 5,
      "summary": {
        "text": "Subsection heading introducing Section E.7 (Antenatal care contact schedules) in Part E of the evidence base web supplement.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "E.7. Antenatal care contact schedules",
      "extractCut": false
    },
    {
      "id": "sec-113-eb-table-e7-focused-anc-fanc-model-minimum-of-fo",
      "number": null,
      "title": "EB Table E.7: Focused ANC (FANC) model (minimum of four visits) versus standard ANC model (minimum of eight visits)",
      "level": 3,
      "pageStart": 119,
      "pageEnd": 121,
      "labelStart": "111",
      "labelEnd": "113",
      "words": 376,
      "summary": {
        "text": "Evidence base table (EB Table E.7) from the Cochrane review by Dowswell et al. (2015) comparing the focused antenatal care (FANC) model (minimum of four visits) against the standard ANC model (minimum of eight visits) across cluster-randomized trials. Summarizes GRADE evidence showing increased perinatal mortality with the reduced-visit FANC model (3 cluster RCTs, 51 323 births; RR 1.15, 95% CI 1.01–1.32; moderate certainty), with little or no difference between models in caesarean section (1 cluster RCT, 22 745 women; RR 1.00, 95% CI 0.89–1.11; high certainty), maternal death (3 cluster RCTs, 51 504 women; RR 1.13, 95% CI 0.50–2.57; low certainty), pre-eclampsia (3 cluster RCTs, 48 853 women; RR 0.94, 95% CI 0.73–1.22; very low certainty), low birth weight (3 cluster RCTs, 46 220 births; RR 1.04, 95% CI 0.97–1.12; moderate certainty), small-for-gestational-age infants (2 cluster RCTs, 37 951 births; RR 1.01, 95% CI 0.90–1.14; low certainty), or preterm birth (3 cluster RCTs, 48 094 births; RR 0.99, 95% CI 0.91–1.08; moderate certainty).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "fanc model",
          "heading": true
        },
        {
          "term": "anc model",
          "heading": true
        },
        {
          "term": "standard anc",
          "heading": true
        },
        {
          "term": "indirectness serious",
          "heading": false
        },
        {
          "term": "serious inconsistency",
          "heading": false
        },
        {
          "term": "serious imprecision",
          "heading": false
        },
        {
          "term": "serious none",
          "heading": false
        },
        {
          "term": "trials serious",
          "heading": false
        }
      ],
      "extract": "Source: Dowswell T, Carroli G, Duley L, Gates S, Gülmezoglu AM, Khan-Neelofur D, Piaggio G. Alternative versus standard packages of antenatal care for low-risk pregnancy. Cochrane Database Syst Rev. 2015;(7):CD000934. Quality assessment No. of women1 Effect2 Certainty No. of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations FANC model Standard ANC model Relative (95% CI)",
      "extractCut": true
    },
    {
      "id": "sec-114-search-strategies-for-the-evidence-base",
      "number": null,
      "title": "Search strategies for the evidence base",
      "level": 2,
      "pageStart": 121,
      "pageEnd": 121,
      "labelStart": "113",
      "labelEnd": "113",
      "words": 6,
      "summary": {
        "text": "Section heading introducing the final part of the web supplement detailing the search strategies used to assemble the guideline evidence base.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Search strategies for the evidence base",
      "extractCut": false
    },
    {
      "id": "sec-115-1-search-strategy-to-identify-existing-anc-guide",
      "number": "1",
      "title": "Search strategy to identify existing ANC guidelines",
      "level": 1,
      "pageStart": 121,
      "pageEnd": 121,
      "labelStart": "113",
      "labelEnd": "113",
      "words": 176,
      "summary": {
        "text": "Describes the December 2013 systematic search strategy used to identify existing evidence-based clinical practice guidelines on antenatal care published after January 2000 across PubMed, LILACS, the Trip Database, the Geneva Foundation for Medical Education and Research (GFMER) guidelines repository, and reference lists, detailing the database-specific search terms and filters.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "search",
          "heading": true
        },
        {
          "term": "practice guidelines",
          "heading": false
        },
        {
          "term": "clinical practice",
          "heading": false
        },
        {
          "term": "prenatal",
          "heading": false
        },
        {
          "term": "trip",
          "heading": false
        }
      ],
      "extract": "In December 2013, a systematic search was conducted for evidence-based guidelines in the following databases: PubMed,5 LILACS6 (an index of scientific and technical literature of Latin America and the Caribbean) and Trip7 (Turning Research into Practice), and in the guidelines repository maintained by the Geneva Foundation for Medical Education and Research (GFMER). To identify as many relevant guidelines as",
      "extractCut": true
    },
    {
      "id": "sec-116-search-results",
      "number": null,
      "title": "Search results",
      "level": 3,
      "pageStart": 121,
      "pageEnd": 122,
      "labelStart": "113",
      "labelEnd": "114",
      "words": 119,
      "summary": {
        "text": "Presents the search results and screening flow diagram (citing Abalos et al., 2016) for existing antenatal care guidelines across PubMed (n = 990), Trip Database (n = 844), LILACS (n = 38), and GFMER (n = 14), narrowing 1886 initial records and 6 additional records from reference checking and expert identification to 133 potentially eligible papers and 85 selected guidelines (15 general ANC guidelines and 70 condition-specific guidelines).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "anc guidelines",
          "heading": false
        },
        {
          "term": "antenatal care",
          "heading": false
        },
        {
          "term": "evidence base",
          "heading": false
        },
        {
          "term": "pubmed",
          "heading": false
        }
      ],
      "extract": "4 Abalos A, Chamillard M, Diaz V, Tunçalp Ö, Gülmezoglu AM. Antenatal care for healthy pregnant women: a mapping of interventions from existing guidelines to inform the development of new WHO guidance on antenatal care. BJOG. 2016;123(4):519–28. doi:10.1111/1471- 0528.13820. 5 Available at: https://www.ncbi.nlm.nih.gov/pubmed/ 6 Available at: http://lilacs.bvsalud.org/en/ 7 Available at:",
      "extractCut": true
    },
    {
      "id": "sec-117-2-search-strategy-for-qualitative-meta-synthesis",
      "number": "2",
      "title": "Search strategy for qualitative meta-synthesis of women’s views",
      "level": 1,
      "pageStart": 122,
      "pageEnd": 122,
      "labelStart": "114",
      "labelEnd": "114",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-118-inclusion-criteria",
      "number": null,
      "title": "Inclusion criteria",
      "level": 3,
      "pageStart": 122,
      "pageEnd": 122,
      "labelStart": "114",
      "labelEnd": "114",
      "words": 201,
      "summary": {
        "text": "Specifies the five inclusion criteria (study design, study topic/focus on routine ANC, population of pregnant or postnatal women since 1998, publication date range of January 2000 to August 2014 following the introduction of FANC, and no language restrictions) for the qualitative evidence synthesis of pregnant women's views and experiences of routine antenatal care.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "language restrictions",
          "heading": false
        },
        {
          "term": "studies published",
          "heading": false
        },
        {
          "term": "date range",
          "heading": false
        },
        {
          "term": "translated",
          "heading": false
        },
        {
          "term": "focused",
          "heading": false
        },
        {
          "term": "women",
          "heading": false
        }
      ],
      "extract": "i. Study design n n Studies using qualitative designs, including ethnography, phenomenology, case studies, grounded theory and mixed methods. n n Studies using interviews, focus group discussions, open-ended survey questions, diaries and other narrative- based data collection methods. ii. Study topic/focus n n Studies focused on, or with substantial sections focused on, views, attitudes, experiences, facilitators",
      "extractCut": true
    },
    {
      "id": "sec-119-search-terms",
      "number": null,
      "title": "Search terms",
      "level": 3,
      "pageStart": 122,
      "pageEnd": 124,
      "labelStart": "114",
      "labelEnd": "116",
      "words": 447,
      "summary": {
        "text": "Details the five-column search term matrix (Participants, Area of Interest, Context, Phenomenon of interest, and Study design), dual-reviewer screening and citation-chaining procedures, and the seven databases searched (AJOL, AMED, CINAHL, Embase, Latindex, MEDLINE, and PsycINFO, plus Zetoc alerts across > 50 journals) for the Cochrane qualitative evidence synthesis on factors influencing pregnant women's uptake of routine antenatal services (Downe et al., 2016, CD012392).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "search",
          "heading": true
        },
        {
          "term": "evidence base",
          "heading": false
        },
        {
          "term": "search strategies",
          "heading": false
        },
        {
          "term": "pregnancy experience",
          "heading": false
        },
        {
          "term": "antenatal care",
          "heading": false
        },
        {
          "term": "web supplement",
          "heading": false
        },
        {
          "term": "reference lists",
          "heading": false
        },
        {
          "term": "journals",
          "heading": false
        }
      ],
      "extract": "Participants Area of Interest Context Phenomenon of interest Study design woman OR women* OR patient* OR consumer* OR service user*] Antenatal* or prenatal* or antepartum or perinatal or pregnan* care OR support* OR health* OR clinic* or outpatient* OR session* OR matern* OR service* OR office or education* want* OR like OR desire* OR require* OR expect* OR anticipat* OR view* OR experience* OR perspective* OR",
      "extractCut": true
    },
    {
      "id": "sec-120-3-search-strategy-for-qualitative-meta-synthesis",
      "number": "3",
      "title": "Search strategy for qualitative meta-synthesis of health-care providers’ views",
      "level": 1,
      "pageStart": 124,
      "pageEnd": 124,
      "labelStart": "116",
      "labelEnd": "116",
      "words": 2,
      "summary": {
        "text": "Subsection heading introducing Section 3 of the search strategies, covering the qualitative meta-synthesis of health-care providers' views on routine antenatal care.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "providers’ views16",
      "extractCut": false
    },
    {
      "id": "sec-121-inclusion-criteria",
      "number": null,
      "title": "Inclusion criteria",
      "level": 3,
      "pageStart": 124,
      "pageEnd": 125,
      "labelStart": "116",
      "labelEnd": "117",
      "words": 411,
      "summary": {
        "text": "Outlines the five inclusion criteria (qualitative/mixed-methods study design, focus on routine ANC provision, population of skilled birth attendants per the 2004 WHO/ICM/FIGO definition as well as paid auxiliary and lay health workers in primary, secondary, or tertiary care, publication date range of January 2000 to August 2014, and no language restrictions) for the qualitative evidence synthesis of health-care providers' views and experiences (citing Downe et al., 2016).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "birth attendant",
          "heading": false
        },
        {
          "term": "skilled birth",
          "heading": false
        },
        {
          "term": "anc services",
          "heading": false
        },
        {
          "term": "antenatal care",
          "heading": false
        },
        {
          "term": "routine antenatal",
          "heading": false
        },
        {
          "term": "language restrictions",
          "heading": false
        },
        {
          "term": "studies published",
          "heading": false
        },
        {
          "term": "date range",
          "heading": false
        }
      ],
      "extract": "i. Study design n n Studies using qualitative designs, including ethnography, phenomenology, case studies, grounded theory and mixed methods. n n Studies using interviews, focus group discussions, open-ended survey questions, diaries and other narrative- based data collection methods. ii. Study topic/focus n n Studies focused on, or with substantial sections focused on, views, attitudes, experiences, facilitators",
      "extractCut": true
    },
    {
      "id": "sec-122-search-terms",
      "number": null,
      "title": "Search terms",
      "level": 3,
      "pageStart": 125,
      "pageEnd": 125,
      "labelStart": "117",
      "labelEnd": "117",
      "words": 318,
      "summary": {
        "text": "Presents the search term matrix (Participants, Area of Interest, Context, Phenomenon of interest, and Study design) and dual-reviewer screening, consensus adjudication, and back-/forward-chaining procedures for the qualitative meta-synthesis of health-care providers' views on routine antenatal care.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "search",
          "heading": true
        },
        {
          "term": "reference lists",
          "heading": false
        },
        {
          "term": "abstract",
          "heading": false
        },
        {
          "term": "inclusion",
          "heading": false
        },
        {
          "term": "terms",
          "heading": true
        },
        {
          "term": "interest",
          "heading": false
        },
        {
          "term": "provider",
          "heading": false
        },
        {
          "term": "qualitative",
          "heading": false
        }
      ],
      "extract": "Participants Area of Interest Context Phenomenon of interest Study design Staff or provider or health care provider or nurs* or midwife* or physician or doctor or medical or faculty or skilled birth attendant or auxiliary or lay or obstet* or workforce or personnel Antenatal* or prenatal* or antepartum or perinatal or pregnan* Care or support or health or clinic or outpatient* or office or education* or parentcraft",
      "extractCut": true
    },
    {
      "id": "sec-123-databases-and-other-sources",
      "number": null,
      "title": "Databases and other sources",
      "level": 3,
      "pageStart": 125,
      "pageEnd": 126,
      "labelStart": "117",
      "labelEnd": "118",
      "words": 73,
      "summary": {
        "text": "Lists the electronic databases (AJOL, AMED, CINAHL, Embase, Latindex, MEDLINE, and PsycINFO) and Zetoc journal alerts (> 50 journals) searched for the qualitative meta-synthesis of health-care providers' views on antenatal care.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "journals",
          "heading": false
        },
        {
          "term": "evidence base",
          "heading": false
        },
        {
          "term": "allied",
          "heading": false
        }
      ],
      "extract": "African Journals OnLine (AJOL), The Allied and Complementary Medicine Database (AMED), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, Online Regional Information System for Scientific Journals from Latin America, the Caribbean, Spain and Portugal (Latindex), MEDLINE and PsycINFO. In addition, Zetoc alerts were set up for over 50 relevant journals. Web supplement: WHO recommendations on",
      "extractCut": true
    },
    {
      "id": "sec-124-4-search-strategy-for-the-review-of-factors-affe",
      "number": "4",
      "title": "Search strategy for the review of factors affecting implementation of the WHO ANC guideline/recommendations (i.e. the 2016 WHO ANC model) – large-scale programme evaluation",
      "level": 1,
      "pageStart": 126,
      "pageEnd": 128,
      "labelStart": "118",
      "labelEnd": "120",
      "words": 704,
      "summary": {
        "text": "Describes the three-part methodology for the large-scale programme evaluation review of factors affecting implementation of the WHO ANC guideline/FANC model: (i) electronic database searches (CENTRAL, MEDLINE, Embase, CINAHL Plus, Global Health, and POPLINE from 2000/2002 onwards using Cochrane ANC terms and the LMIC filter) plus grey literature from ministries of health and partner organizations; (ii) purposively sampled key informant interviews (up to five stakeholders per country case) analysed thematically using the SURE checklist; and (iii) compilation of country case profiles covering demographic, economic, maternal/neonatal health, resource, and ANC coverage indicators from WHO and World Bank datasets.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "anc model",
          "heading": true
        },
        {
          "term": "search strategy",
          "heading": true
        },
        {
          "term": "focused anc",
          "heading": false
        },
        {
          "term": "unpublished literature",
          "heading": false
        },
        {
          "term": "antenatal care",
          "heading": false
        },
        {
          "term": "search strategies",
          "heading": false
        },
        {
          "term": "web supplement",
          "heading": false
        },
        {
          "term": "country case",
          "heading": false
        }
      ],
      "extract": "of the WHO ANC guideline/recommendations (i.e. the 2016 WHO ANC model) – large-scale programme evaluation Search strategy i. Electronic database searching and grey literature For peer-reviewed literature, searches were conducted in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL Plus, Global Health and POPLINE, using a broad search strategy, with a date restriction to include",
      "extractCut": true
    },
    {
      "id": "sec-125-5-search-strategy-for-indirect-evidence-for-heal",
      "number": "5",
      "title": "Search strategy for indirect evidence for health systems interventions",
      "level": 1,
      "pageStart": 128,
      "pageEnd": 128,
      "labelStart": "120",
      "labelEnd": "120",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-126-background",
      "number": null,
      "title": "Background",
      "level": 3,
      "pageStart": 128,
      "pageEnd": 128,
      "labelStart": "120",
      "labelEnd": "120",
      "words": 291,
      "summary": {
        "text": "Explains the rationale, inclusion criteria (systematic reviews published since 2011 with relevant interventions and scoping outcomes), and exclusion criteria (major methodological limitations, low or very low certainty before downgrading for indirectness, or provider-targeted communication interventions) for searching indirect evidence on three health systems priority questions: group ANC, communication and support interventions for pregnant women and communities, and woman-held ANC case notes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indirect evidence",
          "heading": false
        },
        {
          "term": "direct evidence",
          "heading": false
        },
        {
          "term": "anc",
          "heading": false
        },
        {
          "term": "pregnant women",
          "heading": false
        },
        {
          "term": "criteria",
          "heading": false
        },
        {
          "term": "media",
          "heading": false
        },
        {
          "term": "agreed",
          "heading": false
        },
        {
          "term": "interventions",
          "heading": false
        }
      ],
      "extract": "The technical team considered the evidence base for the priority questions on health systems interventions and made the judgement that indirect evidence of effects, to add to the existing direct evidence, should be searched for three of the questions being considered: 1. Should group ANC be recommended as an alternative to standard ANC? 2. What kind of interventions should be recommended to communicate with, and",
      "extractCut": true
    },
    {
      "id": "sec-127-methods",
      "number": null,
      "title": "Methods",
      "level": 3,
      "pageStart": 128,
      "pageEnd": 129,
      "labelStart": "120",
      "labelEnd": "121",
      "words": 368,
      "summary": {
        "text": "Describes the rapid search methods used to identify indirect systematic review evidence in PDQ ('pretty darn quick') Evidence (using MeSH and PubMed index terms from direct reviews for group ANC and patient-held notes) and the Cochrane Consumers and Communication Review Group register (for communication and support interventions), followed by the back-matter ISBN (978 92 4 154991 2) and contact details for the WHO Departments of Reproductive Health and Research, Maternal, Newborn, Child and Adolescent Health, and Nutrition for Health and Development.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "relevant reviews",
          "heading": false
        },
        {
          "term": "indirect evidence",
          "heading": false
        },
        {
          "term": "avenue appia",
          "heading": false
        },
        {
          "term": "search terms",
          "heading": false
        },
        {
          "term": "organization avenue",
          "heading": false
        },
        {
          "term": "fax",
          "heading": false
        },
        {
          "term": "technical team",
          "heading": false
        },
        {
          "term": "health organization",
          "heading": false
        }
      ],
      "extract": "Members of the technical team discussed how to maximize the possibility of finding relevant indirect evidence in the time available. The following was agreed upon: For questions 1 and 3 above, PDQ (“pretty darn quick”) Evidence21 was initially searched for relevant reviews for group ANC (searching for “group care” for question 1, and “patient-held notes” for question 3). It was then determined to search terms by",
      "extractCut": true
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 0,
        "items": []
      },
      "found_not_listed": {
        "count": 11,
        "items": [
          "6 Preterm birth",
          "7 Congenital anomalies",
          "8 Perinatal mortality",
          "9 Stillbirth",
          "10 Neonatal mortality",
          "6 Preterm birth",
          "7 Congenital anomalies",
          "8 Perinatal mortality",
          "9 Stillbirth",
          "20 Avenue Appia, 1211 Geneva 27 Switzerland Fax: +41 22 791 4171 Email: reproductivehealth@who.int Website: www.who.int/reproductivehealth",
          "20 Avenue Appia, 1211 Geneva 27 Switzerland Fax: +41 22 791 4156 Email: nutrition@who.int"
        ]
      },
      "page_mismatch": {
        "count": 0,
        "items": []
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "indirectness serious",
      "heading": false
    },
    {
      "term": "inconsistency serious",
      "heading": false
    },
    {
      "term": "trials serious",
      "heading": false
    },
    {
      "term": "serious none",
      "heading": false
    },
    {
      "term": "imprecision serious",
      "heading": false
    },
    {
      "term": "bias serious",
      "heading": false
    },
    {
      "term": "serious risk",
      "heading": false
    },
    {
      "term": "serious reporting",
      "heading": false
    },
    {
      "term": "randomized trials",
      "heading": false
    },
    {
      "term": "relative effect",
      "heading": false
    },
    {
      "term": "pregnancy experience",
      "heading": true
    },
    {
      "term": "web supplement",
      "heading": true
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "i",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "ii",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 3,
      "label": "iii",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 4,
      "label": "iv",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 5,
      "label": "v",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 6,
      "label": "vi",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 7,
      "label": "vii",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 8,
      "label": "viii",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 9,
      "label": "1",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 10,
      "label": "2",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 11,
      "label": "3",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 12,
      "label": "4",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 13,
      "label": "5",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 14,
      "label": "6",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 15,
      "label": "7",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 16,
      "label": "8",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 17,
      "label": "9",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 18,
      "label": "10",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 19,
      "label": "11",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 20,
      "label": "12",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 21,
      "label": "13",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 22,
      "label": "14",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 23,
      "label": "15",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 24,
      "label": "16",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 25,
      "label": "17",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 26,
      "label": "18",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 27,
      "label": "19",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 28,
      "label": "20",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 29,
      "label": "21",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 30,
      "label": "22",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 31,
      "label": "23",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 32,
      "label": "24",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 33,
      "label": "25",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 34,
      "label": "26",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 35,
      "label": "27",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 36,
      "label": "28",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 37,
      "label": "29",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 38,
      "label": "30",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 39,
      "label": "31",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 40,
      "label": "32",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 41,
      "label": "33",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 42,
      "label": "34",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 43,
      "label": "35",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 44,
      "label": "36",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 45,
      "label": "37",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 46,
      "label": "38",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 47,
      "label": "39",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 48,
      "label": "40",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 49,
      "label": "41",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 50,
      "label": "42",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 51,
      "label": "43",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 52,
      "label": "44",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 53,
      "label": "45",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 54,
      "label": "46",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 55,
      "label": "47",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 56,
      "label": "48",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 57,
      "label": "49",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 58,
      "label": "50",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 59,
      "label": "51",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 60,
      "label": "52",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 61,
      "label": "53",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 62,
      "label": "54",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 63,
      "label": "55",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 64,
      "label": "56",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 65,
      "label": "57",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 66,
      "label": "58",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 67,
      "label": "59",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 68,
      "label": "60",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 69,
      "label": "61",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 70,
      "label": "62",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 71,
      "label": "63",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 72,
      "label": "64",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 73,
      "label": "65",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 74,
      "label": "66",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 75,
      "label": "67",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 76,
      "label": "68",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 77,
      "label": "69",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 78,
      "label": "70",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 79,
      "label": "71",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 80,
      "label": "72",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 81,
      "label": "73",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 82,
      "label": "74",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 83,
      "label": "75",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 84,
      "label": "76",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 85,
      "label": "77",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 86,
      "label": "78",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 87,
      "label": "79",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 88,
      "label": "80",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 89,
      "label": "81",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 90,
      "label": "82",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 91,
      "label": "83",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 92,
      "label": "84",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 93,
      "label": "85",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 94,
      "label": "86",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 95,
      "label": "87",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 96,
      "label": "88",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 97,
      "label": "89",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 98,
      "label": "90",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 99,
      "label": "91",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 100,
      "label": "92",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 101,
      "label": "93",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 102,
      "label": "94",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 103,
      "label": "95",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 104,
      "label": "96",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 105,
      "label": "97",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 106,
      "label": "98",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 107,
      "label": "99",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 108,
      "label": "100",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 109,
      "label": "101",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 110,
      "label": "102",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 111,
      "label": "103",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 112,
      "label": "104",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 113,
      "label": "105",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 114,
      "label": "106",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 115,
      "label": "107",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 116,
      "label": "108",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 117,
      "label": "109",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 118,
      "label": "110",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 119,
      "label": "111",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 120,
      "label": "112",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 121,
      "label": "113",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 122,
      "label": "114",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 123,
      "label": "115",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 124,
      "label": "116",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 125,
      "label": "117",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 126,
      "label": "118",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 127,
      "label": "119",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 128,
      "label": "120",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 129,
      "label": "121",
      "source": "pdf-labels",
      "confidence": 0.7
    }
  ],
  "figures": [],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 142,
      "note": "inferred"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 129,
      "note": "3 levels"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "not-extracted",
      "note": "a glossary section is in the text (p1); its entries are not extracted"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "partial",
      "count": 123,
      "note": "123 of 129 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/9789241549912-websupplement-eng"
  }
}
